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Abstract
Asthma is a highly prevalent and often serious condition causing significant illness and
sometimes death. It typically consumes between 1-3% of the medical budget in most
countries and imposes a disease burden on society comparable to schizophrenia or cir-
rhosis of the liver. Its causes are as yet unknown but a significant number of risk
factors, covering such diverse factors as viral infections during infancy, blood antibody
titres, mode of birth and number of siblings have been identified. In recent years there
has been increasing recognition of the role played by the microbiome in human health,
with a growing understanding that our relationship with the microbes that colonise the
different parts of the human body is symbiotic. Disruptions in the microbiome have
been implicated in diseases such as obesity, autism and auto-immune diseases, as well
as asthma.
At the same time there has been an increasing awareness in asthma research that
its multi-facted and multi-factorial nature requires more sophistication than statistical
association and regression. In this spirit we employ Bayesian networks, whose properties
render them suitable for representing time-direct or even causal relationships, to gain
insight into the nature of asthma.
We begin with an example of the simplest Bayesian networks, a linear classifier,
with which we predict outcomes in the fifth year-of-life according to the statistical
distribution of variables from the first two years-of-life. (The qualification linear refers
to the neglect of correlation and interaction among the predictive variables.)
While classifiers have long been used for prognosis and diagnosis, we use them to
ii
identify useful asthma subtypes, called endotypes. Different endotypes often require dif-
ferent treatments and management programs, and driven by different biological factors.
These different factors provide different predictors, and a predictor which separates one
endotype from the healthy may not do so for a different endotype. We use this to math-
ematically construct an indicator of when a given predictor is exclusively predictive of
a given endotype. Our so-called “exclusivity index” is quantitatively precise, unlike a
significance threshold.
The Cohort Asthma Study, whose longitudinal data we analyse, includes the rela-
tive abundances of genera present in the nasopharyngeal microbiome. In an apparent
diversion, we use qq-plots to indicate relationships between the infant microbiome and
fifth-year wheeze- and atopy- status. Interestingly, the relative abundance of Strep-
tococcus under certain circumstances was found to be highly predictive of one of the
endotypes we identified in the preceding chapter.
Finally, we address the problem of mapping out the complicated interactions among
multiple variables. Our model is an adaption of a package originally designed for infer-
ring gene-interaction networks, called ARTIVA. This was a non-trivial matter requiring
us to augment the discrete data values in order to make them compatibile with the
underlying mathematics of ARTIVA’s algorithm. With questions from the asthma lit-
erature and the posterior probabilities output by ARTIVA, we were guided to networks
of the interactions between atopy, wheeze and infection, and could see the difference in
the development of immunity-related variables between those who went on to exhibit
wheeze in the fifth year-of-life and those who did not. Our model yielded networks
indicating that sensitivity to viral infection is an effect and not a cause of atopy and
wheeze.
Statement of Contents
This thesis is submitted for candidature for the degree of Master of Philosophy.
The candidate declares that the contents of this thesis are entirely his own work, except
where due reference has been made.
This thesis is less than 50,000 words in length, including all tables and captions.

Acknowledgements
This work was done under the supervision of Associate Professor Michael Tadao Inouye.
The candidate also thanks the other members of his thesis committee, Professors Paul
Waring, Gary Anderson and Sally Wood, for helpful discussions and other involvement.
Helpful discussions with other members of the Inouye Lab are also appreciated. The
candidate thanks Dr Gad Abraham, Dr Shu-Mei Teo and Dr Howard Tang in particular.
This thesis was written as part of the NHMRC grant APP1049539, and its desired
results were part of that project’s aims. The candidate also thanks the Department
of Pathology (MDHS) at the University of Melbourne for additional support from the
Beaney Scholarship for two years from 2013 to 2015.




Chapter 1: Introduction 1
1.1 Relevance and importance . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Conceptual framework . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Outline of thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Chapter 2: Literature Review 7
2.1 Asthma pathogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.1.1 What is asthma? . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.1.2 Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.1.3 Clinical presentation . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.1.4 Role of immune system . . . . . . . . . . . . . . . . . . . . . . . 11
2.1.5 Role of early-childhood viral infections . . . . . . . . . . . . . . . 12
2.1.6 Nasopharyngeal microbiome . . . . . . . . . . . . . . . . . . . . . 14
2.1.7 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.2 Literature Review - Bayesian Analysis . . . . . . . . . . . . . . . . . . . 15
2.2.1 Bayesian networks . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.2.2 Inferring parameters through Bayesian classification . . . . . . . 17
2.2.3 Implementation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.2.4 Dynamic Bayesian networks . . . . . . . . . . . . . . . . . . . . . 20
2.3 Classification and prediction . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.3.1 Training and testing . . . . . . . . . . . . . . . . . . . . . . . . . 23
viii Contents
2.3.2 Discriminative classifiers and logistic regression . . . . . . . . . . 24
2.3.3 Generative classifiers and naïve Bayes . . . . . . . . . . . . . . . 24
2.3.4 Generative vs discriminant classifiers . . . . . . . . . . . . . . . . 24
2.3.5 Assumption of independence . . . . . . . . . . . . . . . . . . . . 25
2.3.6 Measuring classifier performance . . . . . . . . . . . . . . . . . . 25
Chapter 3: Asthma endotypes from early-life prediction 29
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.2 Identification of wheeze endotypes . . . . . . . . . . . . . . . . . . . . . . 30
3.2.1 Optimal predictor set for fifth-year wheeze . . . . . . . . . . . . . 30
3.2.2 Predictor set for fifth-year atopic-wheeze . . . . . . . . . . . . . . 31
3.2.3 Optimal predictor set for fifth-year nonatopic-wheeze . . . . . . . 32
3.3 Construction of exclusivity index . . . . . . . . . . . . . . . . . . . . . . 33
3.3.1 Relations between AUCs of general and specific conditions . . . . 33
3.3.2 Relations among specific predictors . . . . . . . . . . . . . . . . . 35
3.3.3 Index of predictor exclusivity . . . . . . . . . . . . . . . . . . . . 36
3.3.4 Illustration of exclusivity equations with atopic- and non-atopic-
wheeze endotypes . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.4 New asthma endotypes, characterised by their atopic triggers . . . . . . 42
3.5 Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Chapter 4: Early NP biome and later wheeze 47
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.2 Inference of predictor and genera interaction from dual qq-plots . . . . . 48
4.2.1 Results from ARI -data in the first 90 days-of-life . . . . . . . . . 48
4.2.2 Fifth-year wheeze from 7-week non-ARI data . . . . . . . . . . . 51
4.3 Prediction of allergen-specific atopic-wheeze from microbiome relative
abundance in infant microbiome data . . . . . . . . . . . . . . . . . . . . 52
4.4 Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
Contents ix
Chapter 5: Inferred dynamic Bayesian networks 63
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
5.2 Technical considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
5.2.1 Independence approximation and choice of variables . . . . . . . 64
5.2.2 Augmented discrete variables in Gaussian process priors . . . . . 65
5.2.3 How we rendered our networks . . . . . . . . . . . . . . . . . . . 65
5.2.4 The effect of missing data . . . . . . . . . . . . . . . . . . . . . . 67
5.2.5 The meaning of intermediate posteriors . . . . . . . . . . . . . . 71
5.2.6 Independent testing of inferred edges with the χ-squared test . . 73
5.3 Atopy, infection, and persistence of wheeze . . . . . . . . . . . . . . . . . 75
5.4 Did LRI lead to atopy and wheeze? . . . . . . . . . . . . . . . . . . . . . 77
5.4.1 Atopy and wheeze led to LRI . . . . . . . . . . . . . . . . . . . . 78
5.4.2 Atopy and wheeze led against URI . . . . . . . . . . . . . . . . . 79
5.4.3 Aeroatopic-wheeze turned URI into LRI . . . . . . . . . . . . . . 81
5.4.4 The importance of viral status . . . . . . . . . . . . . . . . . . . 84
5.5 Viral-LRI s and continuance of atopy . . . . . . . . . . . . . . . . . . . . 87
5.5.1 Viral-LRI s accompanied by airborne-atopy did not lead to airborne-
atopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
5.5.2 Severe-LRI s and the number of atopic triggers . . . . . . . . . . 90
5.5.3 Effect of infection on aeroatopy-number . . . . . . . . . . . . . . 90
5.5.4 Causality runs from aeroatopy-number to severe-viral-LRI in the
first year-of-life . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
5.6 IgE dynamics and future wheeze-status . . . . . . . . . . . . . . . . . . . 94
5.7 Relations among atopic allergens . . . . . . . . . . . . . . . . . . . . . . 97
5.7.1 Multiple atopies and IgE titres . . . . . . . . . . . . . . . . . . . 98
5.8 Altered interleukin dynamics . . . . . . . . . . . . . . . . . . . . . . . . 100
5.9 Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
x Contents
Chapter 6: Discussion 107
6.1 Identification of individual endotypes by classification . . . . . . . . . . 107
6.2 Associations between the NP microbiome and asthmatic outcomes . . . 107
6.3 Results from ARTIVA-derived DBNs . . . . . . . . . . . . . . . . . . . . 108
Chapter 7: Conclusion 111
Appendix A: Multiple predictors and overfitting 113
A.1 Multiple predictors and overfitting . . . . . . . . . . . . . . . . . . . . . 113
A.2 Combining predictors of different quality . . . . . . . . . . . . . . . . . . 114
Appendix B: Augmentation of integer data 119
Appendix C: Numbers of cases and controls for important conditions 121
Appendix D: Numbers of infections 123
Appendix E: QQ-plots to supplement discussion in section 4.2 131
E.1 QQ-plots illustrating the relationship between Haemophilus and fifth-
year atopic-wheeze . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
E.2 QQ-plots illustrating the relationship between Moraxella and fifth-year
wheeze . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
Appendix F: Method for acquiring genera abundances from the NP microbiome 135
F.1 Aspirate sample taking . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
F.2 DNA extraction and bacterial 16S rRNA amplicon sequencing . . . . . . 135
F.3 Quality control and taxonomic assignment . . . . . . . . . . . . . . . . . 136
Appendix G: Posterior legend 139
Appendix H: Mean-imputed DBNs with infection 141
Appendix I: Other supplementary material 147
I.1 Mild-viral-LRI and the number of airborne atopic allergens . . . . . . . 147
Contents xi
I.2 Separating severe-viral-LRI into wheezy- and febrile- viral-LRI . . . . . 148
I.3 Aeroatopy-number and IgE dynamics . . . . . . . . . . . . . . . . . . . 149
Appendix J: Commonly used terms 151
J.1 Respiratory tract infections . . . . . . . . . . . . . . . . . . . . . . . . . 151
J.2 Immunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152





1.1 Relevance and importance
Asthma is currently a serious health issue in Australia and internationally [1–3]. Its
prevalence grew rapidly in the latter half of the twentieth century [1,2] and continues to
rise rapidly in developing countries although it appears to have peaked elsewhere [1,3].
Approximately 250,000 deaths per year are due to asthma while approximately
60,000 people require hospitalisation each year in Australia alone. The economic burden
of asthma in most countries is estimated at 1-3% of the total medical budget [4].
Although the cause of asthma is unknown, many risk factors have been identified.
This study has access to a unique, world-class data resource, the Cohort Asthma Study
(CAS) [5,6]. CAS is a comprehensive longitudinal five-year cohort study, in which risk-
factor relevant data was taken in infancy and then yearly for the first five years of life.
The data was taken from children with family histories of asthma or allergic atopy [5,6],
and includes numbers and types of respiratory infections, immunological factors in the
blood, PCR viral data, and environmental factors such as the presence of older children,
and exposure to cigarette smoke and common allergens. It also contains sequenced 16S
rRNA data from swabs of the nasopharyngeal (NP) microbiome, allowing a detailed
picture of which microbes are present. We studied this data at the genus level for
associations with later wheeze-status. In addition to supporting and expanding on a
result of Teo et al. [7], we also found some new associations between the composition
of the NP microbiome and later wheeze- and atopy- status.
We sought to illuminate the mechanisms of asthma development by identifying time-
sequential, and thus potentially causal, links in this data, and thus pave the way for
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effective treatment and prevention strategies.
1.2 Conceptual framework
We sought to infer new insight into the nature of asthma from the data in CAS. The
data of which we made the most use is related to the number of different types of
infections, IgE titres, and the presence of wheeze, atopy and airborne-atopy. We also
made limited use of interleukin (IL) and interferon (IFN) data. Infections which mani-
fested in the upper respiratory tract but which did not enter the lower respiratory tract
were called upper respiratory infections (URI ). To simplify our notation, we also use
URI to refer to the number of such infections in any given year-of-life, the intended
meaning being clear from context. Similarly, LRI refers to either infections of the lower
respiratory tract (lower respiratory infections) or to the number of them in any given
year-of-life. We apply this dual use across all infection types. An LRI accompanied by
fever is denoted febrile-LRI , or by wheezy-LRI if it is accompanied by wheeze. These
last two infection types are considered severe and denoted severe-LRI . Some severe-
LRI s were both febrile and wheezy, but those that were strictly one or the other are
termed purely-febrile-LRI and purely-wheezy-LRI, respectively. LRI s which were not
severe are considered mild and referred to as mild-LRI. When discussing infections for
which any virii were detected, the corresponding URI s and LRI s are denoted viral-URI
and viral-LRI, respectively. The corresponding terms for when no virus is present are
nonviral-URI and nonviral-LRI, respectively. We also take combinations with fever and
wheeze, such as febrile-viral-LRI, or purely-wheezy-nonviral-LRI, and the same notation
is applied to specific virii , such as Human RhinoVirus (HRV ) or Respiratory Syncytial
Virus (RSV ).
We have adopted the definition of atopy used in CAS [5, 6], where an individual is
deemed to be atopic to a given allergen if the level of IgE antibody in the blood is
greater than .35 kilo-units per litre (kU/L). An individual is considered atopic if they
are atopic to one or more allergens. Airborne-atopy is atopy to an airborne allergen,
and an individual is deemed to have been aeroatopic if they were atopic to at least one
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airborne allergen. The various IgE -related variables describe the concentration of the
corresponding IgE -antibody in kU/L, while interleukin data is measured in picograms
per mol (pg/mol). A detailed list of variables used, either from CAS directly or con-
structed from CAS variables, is given in appendix J.
Since asthma is difficult to define or diagnose, we used the presence of wheeze as
a proxy for asthma, with wheeze in the fifth year-of-life taken to mean that the child
had developed chronic asthma. (Participants in the CAS study were followed up in
the tenth year-of-life, although the attrition rate was too high for us to find confident
results.)
1.3 Outline of thesis
The next chapter contains our reviews of literature relevant to asthma, Bayesian net-
works and classifiers, and explains both biological and mathematical issues to the level
needed to read this work.
In chapter 3 we discerned important predictors and relevant endotypes from the
mathematical properties of linear classifiers. The importance of asthmatic endotypes
has gained increasingly greater recognition in the literature over the past few years [1–4].
The reasons for this include aetiology, triggers, severity, and medication response, all
of which are important for both treatment and research. Crucially, different endotypes
also have different risk factors and may be used to help classify them, so an important
part of this work was demonstrating that certain variables are predictive only of specific
endotypes. We contend that the existence of a predictor exclusive to a given wheezy
endotype is evidence that that endotype is of biological interest.
This is supplemented with an apparent detour in chapter 4 in which we use dual
qq-plots, pairs of qq-plots generated for case and control samples on the same axes,
to detect assocations between the genera in the infant microbiome and later atopy-
and wheeze- status. Apart from identifying some associations in infectious microbiome
samples, we confirm and then explore a recently discovered association [7] between
Streptococcus in early microbiome samples from individuals who were not suffering a
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respiratory infection and later wheeze. The extension culminates in finding Streptococ-
cus, under these conditions, to be highly predictive of a specific atopic-wheeze endotype
presented in section 4.3.
In chapter 5, in order to address questions concerning asthma aetiology and other
developmental details, we inferred time-ordered, relationships among sequential CAS
data. Because of asthma’s multi-factorial nature, our approach was to infer networks,
specifically Bayesian Networks (BNs). These are directed graphs whose directed edges
indicate dependence between nodes, where the nodes represent data fields. To accomo-
date self-interaction and changes in the network over time we specifically used Dynamic
Bayesian Networks (DBNs), in which the network nodes are replicated at every timestep.
There are no edges within a timestep, only between subsequent time steps. This al-
lows a DBN to represent self-interaction by an edge between corresponding nodes in
adjacent timesteps. Indirect self-interaction appears as a directed path starting from
a node, passing through one or more non-corresponding nodes over one or more time
steps, and then returning to the corresponding node at a later timestep. We give a
detailed introduction to DBNs in section 2.2. Our main technical obstacle in this chap-
ter is that the package (ARTIVA) we used to infer the DBNs is inherently unsuitable
for binary and count data, such as the presence or absence of wheeze and the number
of various types of infection. We surmounted this problem with a code module which
augments integer-valued variables with randomly generated continuous variables. Our
chief finding in chapter 5 is that infections, even viral ones, are subsequent to, and
causal of, wheeze and atopy .
We generated the DBNs using the R-package “ARTIVA”. One of the significant
advantages of ARTIVA is that it allows the edges to change over time, with a flexible
number of change points. Its authors could then apply it to the transition between
different phases in the cell growth cycle, and we used it to find critical time points in
asthma susceptibility. For example, in subsection 5.5.4 we find that the relationship
between viral-LRI and the number of allergens to which each participant is atopic
apparently reverses during the first two years-of-life.
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Despite its virtues, ARTIVA required modification in order to be suitable for our
needs. Specifically, it was only suitable for continuous data as its algorithm assumes the
model parameters to have a Gaussian distribution in order to simplify the underlying
mathematics. (This is described in mathematical detail in the supplement of the original
ARTIVA paper [8].) Such an assumption is logically inconsistent with the use of discrete
variables, such as the binary and count variables common in CAS. This problem was
solved by replacing binary and count variables with continuous latent variables, in
accordance with the long-known method of Albert and Chib [9].
Bayes’ formula indicates that posterior probability is a measure of how well a partic-
ular model fits the data. Indeed, with neutral priors the two are proportional. Hence a
relationship between data nodes with intermediate posterior probability suggests that it
is relevant, but with room for improvement. A mediocre fit has several possible causes,
such as nonlinearity and statistical noise, or it could indicate a sub-optimal choice of
data field. For example, a highly probable relationship involving wheezy-LRI should
still fit severe-LRI (wheezy- and febrile- LRI ) quite well since wheezy-LRI is a signif-
icant subset of severe-LRI. But if the relationship did not hold at all for febrile-LRI
then the fit for severe-LRI would be inferior to that for wheezy-LRI. So, given a DBN
involving an intermediate posterior probability involving severe-LRI, we tried replacing
severe-LRI with wheezy-LRI or febrile-LRI to see if it yields a better fit. In this ex-






Asthma development is believed to entail a complex interplay between genetic and
hereditary factors [10]. Furthermore, its manifestation varies greatly over a range of
observables, such as severity [11], asthmatic stimuli [10,12,13] and age-of-onset [14,15].
While many correlations have been identified in the literature, it is not yet understood
which are of direct relevance or form part of any causal relationship. Although it
manifests in the lungs, the pathology derives from an inappropriate immune response
[12,16,17], which may or may not be atopic in nature.
2.1.1 What is asthma?
Asthma is a complicated disease in which the lungs become hypersensitive to various,
typically harmless, stimuli. This leads to an excessive immune response which includes
airway constriction [12, 16, 17]. The strength of this constriction can range from mild
difficulty breathing to a potentially fatal airway restriction requiring strong medication
and hospitalization.
The main clinical symptoms of asthma are shortness of breath, coughing and wheez-
ing, usually in response to specific stimuli such as allergens, infection or exercise [12,
16, 18]. Of course, these stimuli are not specific to asthma, and other factors such as
family history, recurrent bronchitis and response to certain medications might also be
considered.
Asthma displays a variety of phenotypes. One classification scheme [10,12] describes
atopic, non-atopic and transient. Atopic asthma is the “classic” asthma phenotype [10,
16], making ≈ 91% of asthma cases according to some sources [11]. It is accompanied by
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atopic sensitization before the age of three, with attacks triggered by the corresponding
allergens. This is the most common form of asthma, with the biggest risk factors
for asthma development being aeroallergen sensitization [16], and early-onset atopy
[10, 19,20].
However not all asthma is accompanied by atopy, as demonstrated by a study [13]
finding that most, but not all, teenage sufferers of asthma are also atopic, while only
a minority of atopy sufferers have asthma. Asthma without atopy accounted for 19%
of subjects according to one study [19]. While clearly a minority, it is still a significant
minority and one with more severe outcomes [11], including greater loss of lung function
[10, 12, 21] and mortality in later life [21]. This last point is well illustrated by non-
atopic (“intrinsic” in their terminology) asthmatics being over-represented (117 out of
170 asthmatics) in [21], whose subjects were all recruited from the State University
Hospital in Copenhagen. In a ten year follow-up study on intrinsic childhood asthma [22]
furthermore, nearly one third (24 from 70) of the asthmatics were considered intrinsic,
and 20 of those had current symptoms at the ten year follow-up. (The corresponding
proportions were similar, 40 from 46, for the atopic asthmatics.) Importantly, the
outcomes for each of the two asthma types had different predictors, indicating that
they have different underlying mechanisms.
The remaining asthma-related phenotype is transient wheeze. It is characterised by
a wheeze in the first three to five years of life, which is no longer present beyond five
years [10]. This relatively common [20] phenotype was found to typically demonstrate
a reduced lung function prior to infection or other insult, and the lungs continued to
develop along a normal trajectory without attaining full normal function.
Another proposed scheme [15] classifies asthma phenotypes according to age-of-onset
and the concentration of eosinophils (a type of inflammatory cell). It is based on a study
in which early onset (before age 12) wheezers show greater prevalence of allergic triggers
such as dust or pollen, but no difference in non-allergic triggers such as tobacco smoke
and cold air, while late onset (12 or older) wheezers demonstrate lower lung function [3,
11,15,21] despite the absence of significant remodelling [15]. (Remodelling was evaluated
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according to the measured subepithelial basement membrane thickness.) The relevance
of age-of-onset is supported by a study [14] of eight genes, statisticially associated with
asthma before GWAS studies, but not found significant in GWAS studies. The study
identified three SNPs which became statistically significant when age-of-onset was taken
into account. Similarly, a Taiwanese study [23] found that different genes associated
with elevated IgE levels, a risk factor for asthma, were associated with different stages
of development.
Eosinophil data indicates [15] that elevated eosinophil levels, (defined as more than
two standard deviations above the mean), are associated with stronger symptoms, in
both early and late onset asthmatics. There is also a pronounced Th2 (allergy-prone)
pattern of immune cell expression and inflammation pattern associated with eosinophila
among the early onset group but not among the late onset group.
Both early- and late- onset wheezers had both high and low eosinophil subgroups,
but high eosinophil levels were more common among the early onset phenotype. There
is also evidence [3,15] that severe airway restriction can occur in the absence of apparent
inflammation, suggesting a distinct “steroid-resistant” severe asthma phenotype.
A cluster analysis [12] found five clusters with different mixtures of age-of-onset,
severity, atopic status and baseline lung function. This further emphasises the complex
heterogeneity of asthma.
2.1.2 Epidemiology
Asthma, in all its forms, is a significant global health issue. It is currently estimated that
as many as 300 million people have asthma [1–4]. Asthma prevalence rose dramatically
over the latter half of the twentieth century [1, 2]. It continues to rise in developing
countries although developed countries, with higher asthma incidence, have seen its
prevalence level off in more recent years [1,3]. Prevalence in Oceania, among the highest
worldwide, has even dropped slightly (0.39%) [24]. In most countries the economic
burden of asthma is about 1-3% of the total medical budget [4].
Asthma prevalence in Australia, for reasons unknown, is unusually high by world
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standards [1,2]. Australia’s asthma prevalence in various age-groups is about 14-15% [1]
with 27% of Australian children having experienced asthma symptoms by seven years
of age [24].
Asthma is potentially fatal, responsible for approximately one in every 250 deaths
[1], about 250000 deaths each year worldwide [4]. In Australia, 60000 people require
hospitalisation annually [1]. Worldwide around 15 million Daily Adjusted Life Years [4],
about 1% of the total, are lost each year. This is similar to diabetes, cirrhosis of the
liver, or schizophrenia [4]. Many are required to manage their asthma with medication
regimes, which are often unavailable in under-developed countries [4].
2.1.3 Clinical presentation
The clinical symptoms of asthma arise from an exaggeration of three, normally protec-
tive, physiological processes within the lung. The first is that the airways contract due
to tightening of the smooth muscles that line them, narrowing the airways and restrict-
ing the flow of air. The second is the secretion of mucous, which further narrows the
airways with the additional risk of plugging them. The third process is inflammation,
a defense against infection, where the lining of the lung becomes swollen and inflamed,
narrowing the airways further.
In addition to the remarkable increase in degree, these processes also occur much
more readily in the asthmatic lung, typically in reponse to innocuous stimuli. The
changes in lung physiology [16,25–27] contributing to unnecessary sensitivity, excessive
airway constriction, and excessive mucous production are excessive innervation, smooth
muscle thickening and an increased number of the goblet cells responsible for mucous
production. (In chronic asthma the goblet cells spread to the peripheral airways where
they normally do not exist [26].) Other changes include the growth of additional small
blood vessels (angiogenesis), and thickening of the membrane [16, 25–27] under the
epithelial cells lining the airways, causing the lung to lose elasticity and full function.
Some authors have suggested that this is a compensatory mechanism to reduce the
excessive airway constriction [25–27].
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2.1.4 Role of immune system
The remaining asthma pathology is in the immune system, specifically in the relative
proportions of the different immune cell types [15,16,28]. Human immunity is comprised
[29] of two functionally distinct parts, innate immunity and adaptive immunity. Innate
immunity acts as a first line of defense [29,30] against a broad range of foreign organisms,
both through macrophages which attack in response to a limited range of conserved
surface molecules, and through inflammation, mediated by leukocytes, of which there
are several types. Meanwhile, dendritic cells present antigens specific to the infectious
agent to the cells of the adaptive immune system.
The adaptive immune system recognises invasive agents that it has encountered
previously and mounts a strong and rapid response when the same pathogen attacks
again [29]. The major types include B-cells and T-cells [16, 28, 29]. B cells attack
antigens in the blood stream with specific antibodies while T-cells destroy infected
cells and their contents. Both T- and B- cells require priming to a particular antigen
before they mature and become active. This occurs when the immature T- or B- cell is
presented with an antigen by another cell, typically a dendrite [31], a mast cell [32], or
a mature T- or B- cell. Some T-cells, called helper T-cells or Th cells, play a controlling
role, coordinating the immune response. Th1 [30, 33] and Th17 [34] push the immune
system towards an inflammatory response, where Th17 has been implicated in auto-
immune diseases [28, 34]. Th2 favours an adaptive, antibody centred response and
is widely implicated in allergic disease [28, 33], in which the immune system becomes
primed to act against a wide range of innocuous substances such as dust, pollen and
other sources of allergy such as cat dander.
The allergic response is a central feature of asthma. Genetic predisposition for
allergy, specifically for high IgE antibody production in response to allergens, called
atopy, is a major risk factor for asthma [20], especially when the onset is early [6,35–37].
As an illustration of the strength of the genetic overlap between asthma and other
immunity-related disorders, genetic experiments in mice show that immune deficiencies
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can reduce susceptibility to asthma risk factors such as fungi [38] and cigarette smoke
[39]. Other genetic associations show correlation, others anti-correlation, with auto-
immune disease [40].
It is well-known that common allergens often trigger asthma exacerbations (attacks),
and atopic indicators such as blood concentrations of IgE antibodies are risk factors
for asthma. This is well illustrated by one study [19] showing that IgE levels at age
two is a reliable predictor for persistent atopy and wheeze, while another study [41]
has found that house dust mite exposure alters the expression of the immune system’s
T-cells away from the inflammatory Th1 response towards an antibody-oriented Th2
response. There are even genetic factors in common to both asthma and atopy [42].
Allergy symptoms can occur in any part of the body, and it is argued [16, 43] that
an allergic disorder in one organ, such as dermatitis (eczema) in the skin, can lead to
allergic disorders elsewhere, such as the lungs. This “spillover” is thought to result from
dendritic cells in all tissues originating in the same compartment of bone marrow. Hence
sensitivity to air-borne allergens occurs first [16, 44], leading to asthmatic symptoms
later. Atopic march, early dermatitis followed by food allergy and allergic rhinitis (hay
fever) [44] is a well-recognised progression through atopic conditions to asthma probably
due to this mechanism. A similar model in which atopic dermatitus can lead to asthma
has been reported in mice [45, 46], and recent evidence suggests that this might also
occur via bone marrow [47].
2.1.5 Role of early-childhood viral infections
However atopic asthma, even in early onset asthma [15], is only one phenotype of asthma
as discussed earlier. One particularly important non-atopic asthma phenotype is virally-
induced asthma, which Strippoli et al.. [48] concluded was a separate phenotype from
atopic asthma. A relationship between early respiratory viral infection and asthma
development was considered over 30 years ago [49] and subsequently indicated by long-
term birth cohort studies [20] in Australia [19, 50] and overseas [51,52].
Probably because it is the most common serious respiratory infection in newborns
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[53–55], viral studies of asthma pathogenesis are primarily focused on Respiratory
Syncitial Virus (RSV), for which associations have been made [56–58], and contra-
dicted [59, 60] with recurrent wheeze and later asthma and atopy (all studies found an
association with transient wheezing). An analysis by Wennergren and Kristjánsson [60]
found that severe RSV followed by wheeze indicated an underlying mutual cause.
There is now strong evidence that Human RhinoVirus (HRV) is also an important
factor, with several studies finding HRV to have a strong association with asthma exac-
erbation [6,61–63]. (RSV and corona virus have also been found to contribute to asthma
exacerbation [61].) Furthermore, a lower respiratory infection secondary to HRV in chil-
dren is a risk factor for conditions such as asthma, other cardiorespiratory problems [64]
and cystic fibrosis [65].
One of the biggest risk factors for ongoing wheeze and atopy is viral infection in
the presence of early atopy [19, 20, 50, 66, 67]. The conventional view is that suscepti-
bility to viral infection shares a common cause with early atopic sensitization, but an
emerging view [6,16] is that viral infections can exacerbate an atopic condition and even
help its establishment in the lungs. The details are not understood, but cross-linking
mechanisms, similar to those responsible for the atopic march, between atopy and viral
infection have been proposed [6, 16, 55, 68–72]. One of our more important findings is
that this emerging view is not supported by our model.
The central issue is how an anti-viral Th1 response can lead to a Th2 allergic re-
sponse. It has been observed that viral lung infections increase the population of various
dendrites [73,74] and other cells concerned with directing the immune response against
allergens in the lungs, and that some of these numbers remain high post-infection. Hence
an existing atopy in another tissue is assisted into the lungs.
There is also evidence that the dendrites themselves are altered, as some viral infec-
tions up-regulate a key IgE receptor (FcεR1) [16,75], so that Th2 anti-viral inflammation
is effectively recruited to the already existing allergic response, and also furthers allergic
sensitivity via the bone marrow crossover discussed earlier. Such viral exacerbations
also damage the epithelial lining of the lung, further degrading its barrier function and
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leaving it more susceptible to later exacerbations. This closes a vicious circle of in-
flammation, remodelling and loss of lung function, and enhanced hypersensitivity [16],
irreversible once pathological damage has passed a critical level.
2.1.6 Nasopharyngeal microbiome
Bacteria are also relevant to asthma development, though in a different manner to
virii. It is now known that the human body harbours various bacterial microbe colonies
[76–78], and their role in immunity-related disease is an emerging research area [79,80].
The role of microbiota in health generally is still being explored with one recent study
[81] showing a link between the gut microbe colony (microbiome) and obesity in mice.
Another has found that a “healthy” microbiome can provide resistance against intestinal
pathogens [80]. Fujimara et al. [82] found that exposing mice to dust from dogs alters
their gut microbiome and leaves them less vulnerable to airway insult and allergy. It has
also been found [83] that alterations of healthy gut bacteria, especially Bifidobacterium
and Lactobacillus, is a high-risk factor for allergy and asthma. A result in mice, possibly
applicable to humans, is that an unhealthy gut microbiome can even contribute to
autism [84]. Asthmatics have higher levels [16] of bacteria diversity and density in the
nasopharynx (upper part of the airway above the soft palate) although the diversity of
this particular microbiome varies widely even among healthy people [76].
While all this suggests a complex relationship between the microbiome and health,
a reasonable hypothesis is that the nasopharyngeal microbiome could be a source of
opportunistic infection [16, 85], especially given that early microbial colonization is a
risk factor for childhood asthma [86].
It could also be seen as an indicator of a defective immune system [16, 85], with
reduced capacity to clear bacterial and, perhaps, viral incursion. This is supported by
findings that children who develop early asthma and atopy have lower serum concen-
trations of bacterial-specific IgG1 [87,88], as do children susceptible to virally-triggered
asthma exacerbations [89]. Further evidence is that bacteria-specific IgE concentrations
increase after virally induced asthma exacerbations [88], consistent with additional ex-
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posure to a bacterial antigen. Finally, IgE antibodies to Haemophilus and Streptococcus
are protective against asthma [88,90], probably because they are of a relatively soluble
form unsuitable for cross-linking with atopy via the FcεR1 receptor discussed above.
Hence the nasopharyngeal microbiome potentially influences asthma development in
two ways. The first is by influencing the occurence of the allergic response via interaction
with the immune system [83, 90, 91], and the second is as a source of opportunistic
bacterial infection [85].
2.1.7 Summary
Asthma is a complex disease involving complicated interplay among the lungs, various
facets of the immune system [45–47,69], the nasopharyngeal [85,86,92] and other [7,93–
97] microbiomes, and multiple environmental factors including viral infection [19,48,51],
allergen [41, 44] and cigarette smoke [39] exposure, and even exclusive breastfeeding
[50]. To properly demonstrate its origin first of all requires detailed data from deeply
phenotyped cohort models, such as the CAS study in Perth [5,6], the URECA study in
Wisconsin, USA [98] and the MAS study in Germany [51], combined with leading edge
statistical methods.
2.2 Literature Review - Bayesian Analysis
2.2.1 Bayesian networks
Data obtained from studies such as the longitudinal cohort study CAS [5, 6] are con-
ventionally analysed using standard statistical methods [19] to find associations, co-
variances and (usually linear) regressive relationships. While these have undoubtedly
proven valuable [5, 6, 13, 50], there are risks applying a correlation without elucidating
the causal mechanism. For example, a recent publication argued [99] that saturated fat
and cholesterol are not causal of heart disease, despite their long-accepted association,
but may in fact be protective against the stresses that do cause it. If this is so then
the medically advised reduction of fat and cholesterol in western diets may have been
counter-productive. Conventional statistics can rarely derive more than conditional
dependencies without additional input such as intuitive insight or time-sequence data,
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and these fall short of causal relationships in that different causal relationships can have
matching conditional dependencies [100,101].
Analysis of a causal system is greatly assisted by representing it on a Directed Acyclic
Graph (DAG). A graph is a set of nodes, connected by a set of edges. If the edges have a
direction assigned to them then they are called directed edges, running from the parent,
or source node to the child, or target node, and the graph is called a directed graph.
Otherwise they are undirected. The correlations found by conventional statistics can be
represented by an undirected graph if the nodes are made to correspond to the factors
being considered. To represent causal relationships it is necessary to use acyclic directed
graphs1. A graph is acyclic if it is not possible to travel along the edges in the graph
from a node and return to it without traversing any edge more than once. Otherwise it
is called a cyclic graph and is said to contain loops. A directed graph is cyclic only if a
loop can be traversed in the direction assigned to its edges.
While directed edges have an obvious relevance to causal influence, the unidirectional
nature of causality requires a directed graph representing causal relationships to be
acyclic. A Bayesian Network (BN) [102,103] is a DAG representing causal relationships
among statistical data in which nodes also contain the relevant probabilities given the
values of immediately upstream, or parent, nodes.
To find a useful BN, especially among a large number of diverse data fields, requires a
powerful inferencing technique capable of processing large amounts of raw data. Several
machine learning techniques for this are known [104], such as Inferred Causation [100],
minimum message length [105], causal minimal message length [106], and various other
score-based algorithms [107,108]. Kidd et al. [109] have raised similar issues, arguing for
the application of networks, Bayesian methods and information theory in their study of
the immune system.
The simplest Bayesian network is the linear classifier, in which the category being
determined, called the response or response variable, is the parent node to every other
1We use the term causal in the rigorous sense requiring cause to precede effect, as distinct from
simply indicating influence.
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variable in the network, called predictors or predictor variables. We describe it further
in section 2.3. For now we continue with the tools needed to infer networks.
2.2.2 Inferring parameters through Bayesian classification
Bayesian analysis is based on Bayes’ equation [110],
P (Θ = θ|D) = P (D|Θ = θ)P (Θ = θ)∫
dθ′P (D|Θ = θ′)P (Θ = θ′)
, (2.1)
which gives the posterior probability that parameters Θ have value θ given the data D
and a prior expectation P (Θ = θ) (We follow the convention of referring to parameters
with upper-case (Θ) letters and their possible values with lower-case (θ)). This prior,
P (Θ = θ), can be interpreted as prior knowledge or belief, and has historically [111]
been a source of controversy regarding the role of belief and uninformed priors. The
remaining term in the numerator, P (D|θ), is the marginal probability that the data
would be D if Θ = θ, while the denominator integrates over all possibilities to ensure
that the probabilities add up to unity.
We have chosen to use Bayesian inference for its multiple advantages. It is ex-
ceptionally tolerance of missing data [112]. Also, it can formally incorporate known
information by means of a suitably chosen prior distribution or prior. Finally, the
Bayesian approach is theoretically immune to irrelevant data [113] and can therefore be
used to identify which data is relevant. For example, Christensen et al. [114] applied
Bayesian methods to selecting among generalizations of the Dirichlet distribution (Polya
trees) and notes the flexibility provided by Bayesian methods with the desirable feature
that additional data does not complicate a model unless it is truly relevant. We should
however note that implemented algorithms can sometimes fall short of this theoretical
ideal [113,115,116].
The chief Bayesian weakness is vulnerability to correlations among the data fields.
Sometimes these correlations can be very detrimental [117]. Attempted remedies include
propensity scores [118–120], and combinations [121] of Tree Augmented Näive Bayes
(TANs) [122,123], which add links among data fields to weaken the assumption of their
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independence, and greedy [117] search algorithms.
Bayesian vulnerability to correlated data has remarkably little impact on classi-
fication problems [124–126], and these were the focus of early Bayesian applications
[123,127,128]. Indeed, Bayesian classification was applied such diverse topics as quality
of care assessment for hospitals [129] and information retrieval [130]. Later came pre-
diction of outcomes of medical and other procedures [129,131,132] and the association
of genetic data with phenotypes [133]. These methods give the algorithm, usually con-
structed from data, an item’s probability of a certain trait depending on its category.
These probabilities are then fed into Bayes’ equation, eq. (2.1).
We shall use the simplest and most commonly assumed relationship on a Bayesian
network, linear regression [134], where one seeks to infer the linear coefficient. Exam-
ples include Yan et al. [133] who sought associations between SNPs and quantitative
traits. Also, Rigaux et al. [135] used Bayesian regression to assess the risk of bacterial
food contamination. Taking the standard Quantititative Microbial Risk Assessment
(QMRA) model as its prior, the analysis updated about 25% of its parameters, pro-
viding evidence against the QMRA model. (Bayesian analysis has also been applied to
nonlinear functions [136,137].)
2.2.3 Implementation
The computationally difficult part of Bayesian analysis is the integral over parameter
space (the denominator in eq. (2.1)). Techniques for evaluating this integral form the
bulk of research effort in this field. The generally preferred method of evaluating the
integral is the Markov Chain Monte-Carlo (MCMC) technique [103, 138–141]. Monte-
Carlo is the technique of estimating an integral based on randomly selected points. A
Markov chain is usually used to generate the sequence of points, and its defining feature
is that the choice of subsequent point is independent of previous points, although it
may depend upon the current one. (If its dependence on the current point is sufficiently
small it is simpler to implement Tierney’s independence sampler, which assumes inde-
pendence from the current point [142].) If allowed to run for a sufficient period of time
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(called the burn in period), the chain will display a time-independent distribution over
parameter space. The simplest form of MCMC is the Gibb’s sampler [103, 140] , in
which subsequent points are chosen according to the distribution P (θ′) under the inte-
gral. Although it can be applied to multi-variate problems [143], the Gibb’s sampler was
found to only be well-suited to univariate integrals, and poorly suited for meaningful
model comparisons.
These limitations were overcome by generalisation of the Gibb’s sampler to the
Metropolis-Hastings algorithm [103, 138, 139, 141], in which points are proposed and
then accepted or declined with a probability dependent on the marginal likelihood.
The Markov chain is not obligatory. Monte-Carlo methods can be combined [129]
with various stochastic methods including simulated annealing and genetic algorithms.
Carbonetto and Stephens [144] used a combination of variational methods [145–147]
and importance sampling [141] to a Genome Wide Association Study (GWAS) because
the calculation time was much shorter than an MCMC calculation would have been.
However the Markov chain, being widely applicable and computationally efficient, is by
far the most popular choice [141] .
In the examples so far, the network topology is given. Unknown network topologies
are often derived by non-Bayesian methods. Such algorithms typically compare alterna-
tive networks using so-called Bayes’ factors. The Bayes’ factor is the ratio between the
posterior probability of a result and its prior probability. For example, Yu et al. [148]
generated gene networks, comparing the performance of three optimization algorithms,
greedy, simulated annealing, and genetic (the best performer was, due to its speed,
greedy with random restarts).
This reflected a general limitation that MCMC could only select values within a
given model but not yet choose between different models. This was due to different
models not having corresponding parameters or even the same number of degrees of
freedom in parameter space, so that the probability of moves in the Markov chain were
not necessarily independent of direction. Though not strictly essential, conserved de-
grees of freedom ensure that the Metropolis-Hastings algorithm generates an equilibrium
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distribution of the Markov chain [138,139,149].
An early successful application of MCMC to network inference ironically serves to
illustrate this limitation. Tali and Hengartner [150] were able to infer a sequence of
graphs with MCMC only after specifying the number of graphs in the sequence.
The problem of sampling parameter subspaces of different dimensionality was solved
[149] by the reverse jump MCMC (RJ-MCMC) method, in which fictitious degrees of
freedom are randomly generated in transitions involving a change in dimension. A good
description of RJ-MCMC is given by Pagel and Meade [151], which applies it to the
coevolution of multiple male mating and oestrus advertising in primates, where it is used
to infer the branches of a phylogenetic tree. (Also see the discussion in Dellaportas et
al. [143].)
While RJ-MCMC is ideal for inferring graphs, the Bayesian networks described so
far are not suitable for genetic and other biological networks, for two reasons. The first is
that such networks can change their topology over time, such as the network controlling
cell growth, in which gene activity and network topology vary with the phase of the
growth cycle [8, 152, 153]. The second is that they typically contain self-interaction,
either directly as in the case of a gene regulating its own expression, or indirectly as
when a species limits its own population growth [136] by depleting its food supply. Such
self-interaction, also common in genetic networks [154], corresponds to a directed loop,
forbidden in Bayesian networks.
2.2.4 Dynamic Bayesian networks
The solution to both these problems is to replicate the nodes of a Bayesian network at
each of multiple time-points [8, 148, 155, 156]. Edges are only allowed from the nodes
in one time-point to those in the next one. Network changes correspond to changes
in the pattern of edges at corresponding time points, and self-interaction is indicated
by directed paths between corresponding nodes. This construction is called a Dynamic
Bayesian Network (DBN), and is a Bayesian network in its own right.
Robinson and Hartemink [152, 153] inferred a DBN corresponding to a gene net-
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work in drosophilia melanogaster using RJ-MCMC, with the assumption that all genes
changed their connections at the same time. Of course this is not realistic, and a softer
approach [157] was to infer clusters of genes with the same change points, and their
network topologies in a second step.
A DBN whose topological changes were node- (gene-) specific, also corresponding
to a gene network in drosophilia melanogaster was generated from time-series data [8]
by the R-package ARTIVA.
ARTIVA models the network auto-regressively, where each node, apart from the
first timeslice, receives general linear input from the nodes of the previous timeslice.
The regression parameter values are assumed to be normally distributed, the so-called
Gaussian process prior, with a variable covariance σ dependent only on the topology.
This is not only intuitive but also renders the integration over these parameters and σ
analytically tractable [8,158], so the algorithm can effectively ignore them when inferring
the DBN’s topology. Finding the regression parameters is optional, and ARTIVA derives
them from topology only at the end of the algorithm for final output. This approach
was developed in the context of signal processing [158], where the contributions from
each frequency were taken to be normally distributed, given a set of input frequencies
which were inferred by RJ-MCMC.
For our purposes the Gaussian process prior requires the introduction of latent
variables, as it implicitly requires the equation parameters to also have a Gaussian
distribution2. This was not an issue for ARTIVA’s authors [8], whose input was gene-
expression data with a continuous range, but the CAS cohort also includes binary and
interval data. We employed the well-known approach of Albert and Chibb [9], replacing
every discrete target variable Yi with a continuous variable Zi, where Yi equals Zi
rounded off to the nearest integer value. Accordingly, the cutoff values for Zi are at
the half-integers. The minimum integer (usually zero) Ymin has a corresponding Z-
range (−∞, Ymin + 0.5) and the maximum integer Ymax has a corresponding Z-range
2Our thanks to Prof. S. Wood, then of the Melbourne Business School, for alerting us to this issue
and advising this solution.
22 Chapter 2: Literature Review
of (Ymax − 0.5,∞). This is illustrated by the figures in appendix B.
At each iteration the values of Zi are randomly selected from a truncated Gaus-
sian distribution at each iteration, so that the MCMC algorithm is also sampling over
random Gaussian distributions with preference to the more probable ones. The mean
is given by the predictor variables X and the linear coefficients aij at that iteration,
while the truncations are at the boundaries of the appropriate intervals. The complete
development was originally presented in [9].
ARTIVA’s output has the useful feature of providing the posterior probability for
each edge it infers. While its graphs are generated by taking a 50% cutoff, we used this
information to identify meaningful subsets within the data.
The underlying mathematics is simplified by assuming that the linear coefficients
connecting nodes have a Gaussian distribution, otherwise known as the Gaussian process
prior.
The incoming edges for each gene are modified at specific timeslices called change-
points, for which each gene has its own set. Combinations of incoming edges are inferred
for each set of changepoints, where the algorithm moves through the space of possible
edge combinations by either adding or removing possible edges. Likewise, sets of change-
points are sampled by RJ-MCMC, where the permitted steps are the addition, removal
or shifting of a changepoint. A similar approach was taken by Andrieu and Doucet [158]
to infer the number of wave inputs to a given signal.
In this work we used ARTIVA by replacing gene activity with data from the CAS
longitudinal cohort study [5,6], taking advantage of ARTIVA’s ability to infer network
changes [8], as previous studies [19] indicate critical periods in asthma development.
The deficiency of ARTIVA is its assumption of linear relationships. This was of partic-
ular concern to our work because the dynamics of asthma development contain critical
thresholds at which development switches from one track to another, such as the pre-
viously mentioned example of house dust mite IgE titers in the second year-of-life. We
overcame this by placing conditions on the data to distinguish between those who ex-
hibit wheeze in the fifth year-of-life from those who do not, and thus identifying separate
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paths of development corresponding to different asthma phenotypes. In section 5.7 we
find that networks of IgE titres varied between those who developed wheeze in the fifth
year-of-life and those who did not. We found a similar result for interleukin titres.
2.3 Classification and prediction
Some statistics-based algorithms called classifiers can be trained to recognise classes of
objects [121,127,128]. A set of variables, called predictors, whose values are distributed
differently between the classes, are used to make the classification. The values of these
predictor variables are distributed differently between the classes, as expected in a
Bayesian network, and are used to make the classification. An illustrative example
of such a classifier is the spam filter, in which incoming emails are classified as being
either spam or legitimate according to their observable properties. Similarly, clinicians
routinely use medical tests to determine if a patient has a particular disease [131,143].
Prediction is a special class of classification, in which the response variable is con-
cerned with a future property. The future responses of interest to us were centred on
the manifestation of wheeze in the fifth year-of-life, which we take as our proxy for
asthma. We also consider more specific responses such wheeze accompanied by atopy,
or atopic-wheeze, and wheeze not accompanied by atopy, or nonatopic-wheeze. All of
these responses are binary, being either true or false, or positive and negative for the
trait in question. We therefore restrict all discussion of prediction to binary predictors
for the rest of this work.
2.3.1 Training and testing
If the predictor distributions for each class are known, then there are several methods
available to find the probability of each class containing the object being classified.
Usually these distributions need to be determined. The required parameters for each
classifier are found from a test set, a set of samples whose predictors and class are
known. The inferred distributions are then used to find the probability of the subjects
belonging to each class. Classifiers are divided into two categories: [159,160]
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2.3.2 Discriminative classifiers and logistic regression
A discriminative classifier is one which specifies a cutoff and classifies according to which
side of the cutoff the sample is on. In its simplest form, one uses the midpoint between
the means of the two distributions. If we wish to set a cutoff with a probability other
than 50%, then this may calculated either by linear regression, or by logistic regression.
Logistic regression has an S-shaped functional dependence, instead of a linear one,
so the predictor value is related to the probability by log( p1−p). This approximates the
step function, which is a better choice for discriminating between two alternatives.
2.3.3 Generative classifiers and naïve Bayes
A generative classifier is one which trains by finding the class-dependent probability
distributions. This can rarely be done exactly, so it is common to assume that the dis-
tributions are Gaussian. It is also common to assume that the predictors are distributed
independently, or equivalently, that they do not interact. While this is frequently not
the case, and has been shown to be detrimental in some problems [122,161], it has also
been found to work surprisingly well [121, 125, 126]. In fact, some studies have found
that the effort of allowing for interactions can lead to a poorer performance [124].
A generative classifier with these two assumptions is called naïve Bayes.
2.3.4 Generative vs discriminant classifiers
Whether it is the generative or the discriminative classifier which performs better often
depends on the data in question. For small-to-moderate numbers of predictors which
approximately conform to the assumptions of the classifier, it is common for them to
perform equally well. Often the assumptions are not well respected, in which case the
discriminitive classifier would usually have the advantage [127]. In practice it is usually
necessary to make assumptions about the distributions, such as the Gaussian assump-
tion of naïve Bayes. This is a vulnerability not shared by discriminative classifiers.
Generative classifiers do hold an advantage when there are a large number of predic-
tors. This is due to a common but counter-intuitive phenomenon in machine learning
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called overfitting, in which adding additional predictors degrades the classifier’s perfor-
mance. This can be understood as the classifier fitting the data too well, so that it
matches the random fluctuations in the data which are really just noise. Discriminative
classifiers are quite vulnerable to overfitting, especially with small sample sizes or poor
predictors [162]. Generative classifiers are theoretically immune to it [113], but can still
be affected if the data is poor or does not match the classifier’s assumptions very well.
The issue of which classifier is better, and under what circumstances is still contro-
versial [159,160,163].
2.3.5 Assumption of independence
It is common to use linear classifiers which assume that the predictors are completely
independent with no correlation between them. While greatly simplifying the algo-
rithm, neglecting these interactions comes at the cost of ignoring potentially important
information. This is especially true for Bayesian classifiers which require the entire
distribution in principle. While this cost is not always small [117, 131], the literature
abounds (e.g. [123,127,128]) in applications in which naïve Bayesian classification works
considerably better than one might intuitively expect. This was eventually understood
by an information theoretic analysis [126], which found the loss of information to be
the most relevant factor. Other authors argued that attempts to account for correlation
were rarely worth the cost [125], and sometimes self-defeating [124]. The classifiers used
in this work are linear and also make this assumption.
2.3.6 Measuring classifier performance
Classifier performance can be measured in a number of different ways, based on the
fraction of correctly identified cases and/or controls. Which is most appropriate often
depends on the question at hand, and the reader is referred to [162] and references
therein for a thorough discussion. Some commonly used measures are:
True positive rate: the fraction of positive samples which are found to be positive,
True negative rate: the fraction of negative samples which are found to be negative,
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False positive rate: the fraction of negative samples which are found to be positive,
False negative rate: the fraction of positive samples which are found to be negative,
Positive predictive rate: the fraction of positive findings which are truly positive,
Negative predictive rate: the fraction of negative findings which are truly negative.
ROC plot and AUC
While the logical cutoff for differentiating between case and control is at a probability
of 0.5, there are several reasons for choosing differently. For example, a lower cutoff
might be chosen if the cost of a false negative is high. An obvious example of this is
a screening test for a serious medical condition. If the condition is missed then the
patient’s health and even life are at risk so the clinician chooses to err on the side of
caution until a more definitive test is performed. Similarly, a high cutoff might be used
if there is a significant cost associated with false positives and standards of evidence are
required to be high.
One may find the true and false positive rates as a function of the cutoff and plot
it on a pair of axes, as shown in figure 2.1. Such a plot is called a ROC plot, and the
corresponding curve a ROC curve. ROC stands for Receiving Operator Characteristic,
dating to its origins as a way of classifying the accuracy of radar operators in the second
world war.
The area under the ROC-curve, or AUC, is another measure of classifier perfor-
mance, and may be interpreted as the probability that the case will be ranked above
the control when presented with a case-control pair [164].
Cross-validation
Ideally one trains the classifier on one dataset, called the “training set”, and then tests it
on an independent dataset, called the “testing set”. If only one dataset is available, as in
our work, then we may divide it into training and testing sets. (See [165] and references
therein for history and a formal description.) Since limited training data is a limiting
factor on classifier performance, the division is rarely even. Rather, the training set


























Figure 2.1: ROC plot showing ROC curves for logistic regression and
naïve Bayes classifiers predicting wheeze in the fifth year-of-life: The pre-
dictors are a randomly chosen assortment from CAS.
is typically chosen to be from two to ten times the size of the testing set, depending
on the details of the problem. While the division is random, it is also a good idea to
maintain the overall ratio of cases to controls in the two subsets. We found the best
compromise between training and testing with a two-to-one ratio between training and
testing sets so that the testing set was one third of the dataset, but other values are
possible (e.g. [166]).
This works well but is vulnerable to statistical fluctuations among the possible parti-
tions. The natural remedy is to cycle through all possible partitions, or at least enough
of them to smooth out any statistical outliers. A common practice, which we also em-
ploy, is to perform the described procedure 100 times, choosing a different partition
each time, and average over the results.
Other solutions to this problem are in common use, such as “one with replacement”,
where one sample is removed for testing and replaced for the next iteration. We have
mentioned these other methods for the sake of discussion but they have not been em-
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ployed in our work. A review is available in [166].
Summary
We have just described the network-based methods with which we shall study the data-
intensive CAS cohort. The first was a description of ARTIVA, which we have adapted
to handle count data such as the numbers of different types of infection. Next, we
described basic classifiers, based on a very simple BN, their application to prediction,
and the methods of measuring and minimising their errors. We apply these methods
in the next chapter to not only identify which variables make good predictors, but to
probe the endotypic structure of asthma by identifying those which exclusively predict
specific types.
Chapter 3
Asthma endotypes from early-life pre-
diction
3.1 Introduction
As discussed in section 2.1, asthma comes in a variety of forms or endotypes [167,168],
whose phenotypic variation can range over characteristics as varied as triggers, severity,
medication responses, as well as various immunity-related factors. It is not uncommon to
see discussion of eosinophilic vs neutrophilic hypersensitivity [3,15,169], and there have
been increasing calls in the literature [168–170] to consider the more specific endotypes
of asthma as characterised by accompanying comorbidities.
We begin by demonstrating that the atopic and non-atopic wheeze endotypes (re-
member fifth-year wheeze is our proxy for asthma) have different predictors, in agree-
ment with [22], and find optimal predictor sets for each. (Unless stated otherwise, all
predictors were taken from the first two years-of-life.) The best predictor set for fifth-
year atopic-wheeze was also the best one for wheeze in general. This was not surprising
as one of the best known predictors of asthma is derived from titres of house-dust-
mite IgE in the second year-of-life. Also, CAS participants were chosen for a family
history of atopy or asthmatic wheeze. Furthermore, the prediction by (log of) house-
dust-mite IgE of fifth-year atopic-wheeze was better, as measured by the AUC, than its
prediction of fifth-year wheeze. We therefore considered that house-dust-mite IgE ’s pre-
dictive ability for wheeze is really limited to atopic-wheeze, so that prediction of wheeze
in general would be less effective in a different data set with a lower proportional of
atopics among those with fifth-year wheeze.
To demonstrate this we derive equations relating the AUCs from the same clas-
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sifier/predictor combination predicting a general case, say wheeze, and a specific en-
dotype, say atopic-wheeze. We then go on to construct an index of this exclusivity
and used it to identify a new endotype of atopic-wheeze, and exclusive predictors of
nonatopic-wheeze.
3.2 Identification of wheeze endotypes in the fifth year-of-life through
exclusive early-life predictors
We began by seeking the best set of predictors that we could find for wheeze in the
fifth year-of-life. In accordance with the findings of appendix A, we chose our variables
in order of decreasing predictive ability unless the next predictive variable was ex-
pected to be correlated with one that had already been chosen, a compromised greedy
algorithm. This yielded respectable predictions of fifth-year wheeze and better predic-
tions for atopic-wheeze, as measured by the AUC. Repeating this process for fifth-year
nonatopic-wheeze also allowed us to make good predictions.
3.2.1 Optimal predictor set for fifth-year wheeze
Plotting AUC as a function of using the top one-to-twelve predictors for fifth-year wheeze
for both logistic regression and naïve Bayes (figure 3.1), we found a best AUC of .77
from the top three predictors. (All in the second year-of-life, these were (log of) house-
dust-mite IgE, (log of) infant-phadiatop-IgE, and severe-LRI.) Attempts to include more
than these three predictors led, apart from a slight bump at five predictors, to a steadily
lower performance. This diminution in performance from adding additional predictors
was in qualitative accordance with the simulations in appendix A.
Now house-dust-mite is an airborne allergen. If its predictive ability is limited to
atopic endotypes, then the AUC is going to be higher for those specific cases and .5 for
the remaining cases.
We explore this in a more general and quantitative sense in what follows and find
that we can use it to identify biologically distinct endotypes, each with its own specific
predictors, causes, and aetiology.
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3.2.2 Predictor set for fifth-year atopic-wheeze
The AUC scored by (log of) house-dust-mite IgE in the second year-of-life when predict-
ing fifth-year atopic-wheeze was .79, while the top five predictors of fifth-year wheeze,
namely (log of) house-dust-mite IgE, (log of) infant-phadiatop-IgE, severe-LRI, febrile-
LRI and severe-viral-LRI, all from the second year-of-life, combined to score an AUC
of .83 when predicting atopic-wheeze in the fifth year-of-life.
Counting early-life atopies to predict fifth-year atopic-wheeze
The top twelve predictors of atopic-wheeze were IgE titres (or their logarithms) for
house-dust-mite, peanut, or infant-phadiatop, but combining them simply did not lead to
















Figure 3.1: Effect on logistic regression and naïve Bayes AUC as successive
CAS predictors are added to the set of predictors: The predictors were added
in order of decreasing AUC. The performance peaked at three predictors and fell away
more quickly for logistic regression, as expected from our discussion on overfitting in
section 2.3 (see also appendix A). The top 12 predictors, all of which were taken from
the second year-of-life except where otherwise indicated, were, in decreasing order of
predictive power, (log of) house-dust-mite IgE, (log of) infant-phadiatop-IgE, severe-
LRI, febrile-LRI, severe-viral-LRI, (log of) peanut-IgE (first year-of-life), febrile-viral-
LRI, (log of) peanut-IgE, LRI, infant-phadiatop-IgE, wheeze, and airborne-atopy.
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an improved AUC. Even combining the top peanut- and house-dust-mite- IgE predictors
led to no improvement, which suggested to us that either they are each carrying near-
redundant information about the response, or that their class-dependent distributions
are sufficiently correlated to generate errors in the linear classifiers. The correlations
among the cases and the controls were .77 and .35, respectively. While these correlations
are indeed significant, they are much moreso among cases. This difference suggests that
the true risk factor was that both predictors were elevated, given that higher IgE titres
correspond to atopic-wheeze risk [6].
We therefore considered whether the number of allergens which elicit an atopic
response, or atopy-number, might be a predictor of atopic-wheeze in the fifth year-of-life.
(Note that infant-phadiatop and phadiatop are not included in this definition to avoid
double-counting.) Interestingly, atopy-number from the first year-of-life was a better
predictor than from the second. This single predictor, in the first year-of-life, scored an
AUC of .81 predicting fifth-year atopic-wheeze and an AUC of .66 predicting fifth-year
wheeze, second only to the .67 scored by second-year (log of) house-dust-mite IgE.
We also considered the number of airborne allergens to which the participants were
atopic, or aeroatopy-number. Its predictive power was greater in the second year-of-life
(AUC .74) than in the first (AUC .65), but was still lower than for first-year atopy-
number .
We note in passing that when we combined first-year atopy-number with febrile-LRI
from the second year-of-life to predict fifth-year atopic-wheeze the resulting AUC was
.86, well into the excellent range.
3.2.3 Optimal predictor set for fifth-year nonatopic-wheeze
The best predictors for nonatopic-wheeze in the fifth year-of-life were, in decreasing
order of AUC from logistic regression; number-of-older-children-in-the-home-at-birth
(.68), (log of) first- and second- year infant-phadiatop-IgE (.65), then number-of-older-
children-in-the-home (.64), number of HRV (human rhinovirus) infections and trecs
(T-cell receptor excision circles) (.62) from the second year-of-life (.63). We mention
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in passing that the optimal predictor set for nonatopic-wheeze in the fifth year-of-life
was number-of-older-children-in-the-home-at-birth, (log of) infant-phadiatop-IgE from
the first year-of-life, then (log of) infant-phadiatop-IgE, HRV and trecs from the second
year-of-life, with an AUC from naïve Bayes of .75.
3.3 Construction of exclusivity index
Asthma endotypes may be differentiated by the demonstration of separate predictors.
We now proceed to construct and explore an index whose function is to indicate whether
an apparent predictor for a general condition, such as wheeze, is really only predictive
of a given endotype of that condition, such as atopic- or non-atopic- wheeze. While
identifying useful predictors is an obvious incentive for such a tool, we consider the real
value to be in identifying specifically predictable endotypes, reasoning that if it does
have a specific predictor then it is likely to be of biological and/or clinical significance.
3.3.1 Relations between AUCs of general and specific conditions
The AUC is a measure of the accuracy of a classifier, in combination with the predictors
being fed into it. For a given classifier, such as the logistic regression and naïve Bayes
classifiers that we have chosen, it is a measure of the quality of the predictor(s) being
used. As explained in subsection 2.3.6, the AUC is defined as the area under the ROC
curve, but it has another interpretation [164]. If a trained classifier/predictors combi-
nation is presented with a pair of samples, in which one is a case (positive response),
and the other a control (negative response), then the AUC gives the probability of
the classifier/predictors combination finding a higher probability for the case than for
the control. In simpler terms, the classifier’s probability of correctly sorting case from
control by simply playing the odds.
Let us consider a sample set whose cases may be neatly divided into two or more
sub-cases a, b, . . .. For concreteness, the general case could be fifth-year wheeze divided
into fifth-year atopic-wheeze (subcase a) and nonatopic-wheeze (subcase b). For a given
classifier, suppose P1 scored an AUC of auc1a predicting sub-case a but could not
distinguish other general cases from controls. The case-control pairs can then be divided
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into those whose case is a member of a, and those whose is not. The former is predicted
with an AUC of auc1a, the latter with an AUC of .5 which is equivalent to random
guessing. So if P1 is used to predict the general case, then it would score an AUC of
AUC1 = qa auc1a + (1− qa)× .5, (3.1)
where qa is the proportion of cases belonging to sub-case a.
Similarly, if there is a second sub-case b, which does not intersect with a, for which
predictor P2 scores an AUC of auc2b while unable to distinguish other cases, including
a, from controls, then the AUC of P2 predicting the general case would be
AUC2 = qb auc2b + (1− qb)× .5, (3.2)
where qb is the proportion of cases belonging to sub-case b.
If P1, P2 are taken together to predict the general case, then the anticipated AUC
obeys
AUC12 = qa auc1a + qb auc2b + (1− qa − qb)× .5
= AUC1 +AUC2 − .5 (3.3)
since, in the ideal scenario, qa of the cases are distinguished with an accuracy of auc1a, qb
with an accuracy of auc2b, while the rest are randomly guessed. If either of P1, P2 are
predictive of each others’ subclass then that will increase AUC12, but that scenario
is forbidden by equations (3.1) and (3.2). AUC12 is degraded by the introduction of
noise with each additional predictor. The noise is due to P1 randomly guessing cases
of b and P2 randomly guessing cases of a. Further analysis is beyond the scope of our
requirements.
§3.3 Construction of exclusivity index 35
Necessary and sufficient conditions for the exclusivity index to hold
The above derivation of equations (3.1) to (3.3) begins with the assumption of exclu-
sivity, and as such it only demonstrates their necessity for the predictor to be exclusive.
In practice, calculations of AUC vary slightly from one calculation to another, which we
address below by calculating error margins based on AUC uncertainties of ±.01. There
is, in practice, another factor affecting these equations. If the number of sub-cases is
too small a fraction of the more general case, then prediction of the general case can be
adversely affected by noise.
If the predictor is not exclusive to the subcase a then equation (3.1) will underes-
timate the predictor’s score with the general case AUC1. One might therefore expect
equation (3.1) to be a lower bound. The effect on equation (3.3) is more complicated. If,
contrary to founding assumptions, there is overlap between cases a and b then the effect
on AUC12 is harder to ascertain. On the one hand, there is less new information being
brought to the prediction leading to a lower general AUC. On the other hand, where
cases a and b overlap the predictors might combine constructively, so that classification
of either case is more accurate with both predictors. The combination might also be
destructive.
The overall picture then is that any deviation from the founding assumptions used
to derive equations (3.1) to (3.3) will introduce errors, but these might be cancelled by
noise. We therefore take these equations, and the indices we now derive from them, as
strong indicators that the predictor in question is exclusively predictive of the endotype
in question. Care must be taken in the case of rare endotypes whose low case numbers
render them vulnerable to statistical noise. We dealt with this by only using AUCs
found to be statistically significant by the Mann-Whitney U -test. The corresponding
p-values are shown for the rare endotypes we discuss in table 3.5.
3.3.2 Relations among specific predictors
We can also approximate the accuracy with which P1 would predict cases of b, and
P2 cases of a. Since the sub-cases are distinct, the sub-case a also forms a subset of
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non-cases of b. No case of a is also a case of b, so when considering the performance
of P1 predicting b, it is better to break the non-cases of b into a and non-a, predicted
with accuracy auc1a and 0.5, respectively. Recalling that P1 will distinguish cases of a
from cases of b, auc1a of the time, and be randomly guessing otherwise, the AUC of P1
predicting b will be
auc1b = qaauc1a + (1− qa − qb)× .5
= AUC1 − qb × .5, (3.4)
where the final line substitutes equation (3.1). There is a corresponding result predicting
a with predictor P2.
We illustrate with the example of predicting nonatopic-wheeze in the fifth year-of-life
from (log of) house-dust-mite IgE in the second year-of-life. We shall show in section 3.4
that this predictor is exclusive to a specific endotype of airborne-atopy , with absolutely
no overlap with nonatopic-wheeze. Substituting the relevant values into equation (3.4)
finds that this prediction should score an AUC of .47. (The actual AUCs were .49
(logistic regression) and .54 (naïve Bayes). Since these two classifiers usually score
almost identically for single predictors, and given the irregular shape of the ROC curve
(not shown), we attributed the discrepency to a breakdown in the linear relationship
between the predictor and the outcome.) This suggests that a predictor which scored
an AUC below 0.5 for a particular response might be predictive of a separate response.
However, there is no clear indicator of what that response would be, and since there
appears to be no predictive value in this approach we do not pursue it any further.
3.3.3 Index of predictor exclusivity
Our purpose here is to identify distinct endotypes along with their exclusive predictors.
We are not primarily concerned with the value of the AUC, apart from using them in
our calculations, so we have re-arranged equations (3.1-3.4) to put factor .5 on the right-
hand-side. The left-hand-side then becomes a measure of how exclusive the predictor
is to the endotype in question, so we have named it the “exclusivity index”, being .5
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general case wheeze atopic-wheeze
endotype atopic-wheeze aeroatopic-wheeze
variable year (±.05) (±.04) (±.13)
(log of) house-dust-mite IgE 1 .45 .48 .60
(log of) house-dust-mite IgE 2 .49 .51 .58
(log of) infant-phadiatop-IgE 2 .57 .62 .84
peanut-IgE 1 .51 .57 .81
atopy-number 1 .41 .50 .81
atopy-number 2 .51 .52 .57
severe-LRI 2 .71 .74 .87
febrile-LRI 2 .64 .71 1
Table 3.1: Results from substituting AUCs from some of the better predictors
into the exclusivity index (equation (3.5)). For cases of fifth-year wheeze we
have considered both atopic-wheeze and aeroatopic-wheeze. We have also considered
cases of atopic-wheeze with the endotype aeroatopic-wheeze. The error margins given
at the top of the data columns were calculated by substituting an error margin of
±.01 into both AUCs in equation 3.5, and rounding up to the nearest .01. (Log of)
house-dust-mite IgE in the first two years-of-life apparently predicts aeroatopic-wheeze
exclusively, while peanut-IgE in the first year-of-life appears to predict atopic-wheeze,
unsurprisingly, but not aeroatopic-wheeze. The .50 scored by atopy-number in the first
year-of-life concerning the aeroatopic subset of wheeze is probably a fluke, since it scores
badly for the larger atopic subset.
when the predictor is exclusive to within a predetermined error margin. That margin
was found by allowing both AUC1 and auc1a to vary by ±.01.
So, if predictor P1 is exclusively predictive of endotype a then re-arranging equation
(3.1) gives
AUC1 − qa auc1a
1− qa
= .5 (3.5)
with an error margin of ±.01× 1+qa1−qa .
When considering the combination of two non-intersecting endotypes, rearranging
equation (3.3) gives
AUC1 +AUC2 −AUC12 = .5± .03. (3.6)
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variable year index
number-of-older-children-in-the-home-at-birth birth .47
(log of) infant-phadiatop-IgE 1 .59






Table 3.2: Results from substituting AUCs from some of the better predictors
of nonatopic-wheeze into equation (3.5). We are considering cases of fifth-year
wheeze and the endotype of nonatopic-wheeze. An error margin of ±1 has been allowed
for each AUC contributing to the index calculation, leaving a final margin of ±.03.
atopy-number peanut-IgE
number-of-older-children-in-the-home (birth) .46 .52
number-of-older-children-in-the-home (year 2) .50 .54
HRV (year 2) .50 .60
Table 3.3: Index scores for combining predictors of atopic-wheeze from the
first year-of-life and predictors of nonatopic-wheeze to predict wheeze. An
error margin of ±1 has been allowed for each AUC contributing to the index calculation,
leaving a final margin of ±.03. As in table 3.1, atopy-number and peanut-IgE from the
first year-of-life appears to be less-than-solid as exclusive atopic-wheeze predictor. The
other variable pairs conform to equation (3.6).
house-dust-mite atopy-number severe-LRI febrile-LRI
IgE (log)
number-of-older-children-
-in-the-home (birth) .48 .49 .55 .51
number-of-older-children-
-in-the-home (year 2) .50 .50 .56 .53
HRV (year 2) .50 .52 .55 .52
Table 3.4: Index scores for combining predictors of atopic-wheeze from the
first year-of-life and predictors of nonatopic-wheeze to predict wheeze. An
error margin of ±1 has been allowed for each AUC contributing to the index calculation,
leaving a final margin of ±.03. Consistent with table 3.1, the number of neither febrile-
nor severe- LRI s predicts either endotype exclusively. The other variable pairs conform
to equation (3.6).
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3.3.4 Illustration of exclusivity equations with atopic- and non-atopic-
wheeze endotypes
We have seen that the best predictors of wheeze, namely the IgE titres, are clearly of
relevance to atopic-wheeze, with the corresponding AUCs higher for the atopic-wheeze
condition than for the wheeze condition. Equation (3.1) allows us to investigate whether
their predictive ability is limited to atopic-wheeze, so that they are unable to distinguish
nonatopic-wheeze from non-wheeze. Equivalently, do the predictors in question derive
their efficacy for the general case from their predictive atopic endotype being a major-
ity subset (of the 56 participants with fifth-year wheeze, 35 were atopic and 30 were
aeroatopic)?
For reasons that will become clear, we use house-dust-mite IgE in the second year-
of-life as our illustrative example. Its relevance to aeroatopic-wheeze should surprise
noone, but other aeroallergens do not serve this purpose nearly as well. We also point
out that this is more than predicting later atopy from current atopy, as there is no
reason for thresholds related to fifth-year outcomes to match the thresholds for early-
life conditions.
Applying equation (3.1), (log of) house-dust-mite IgE from the second year-of-life
scored an AUC of .76 for prediction of fifth-year atopic-wheeze. For predictions of the







= .66 ≈ .67, (3.7)
in agreement with explicit calculation. Similarly, (log of) house-dust-mite IgE from the
second year-of-life scored a higher AUC of .79 predicting fifth-year aeroatopic-wheeze,







= .66 ≈ .67. (3.8)
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= .75 ≈ .76, (3.9)
where the difference is well-within natural variation of AUC and round-off errors are
worse due to the smaller number of cases.
In such a scenario we can derive an upper bound on how well the general response
can be predicted from variables which predict subsets. Given a perfect predictor of















A more realistic but still optimistic predictor of aeroatopic-wheeze, with an AUC of







predicting fifth-year wheeze. The corresponding figure for atopic-wheeze is .75.
To identify valid endotypes we require not just that they be defined by biological
indicators, but that they have an exclusive predictor which is unpredictive of the non-
endotype. We illustrate this by using (log of) house-dust-mite IgE from the second
year-of-life to demonstrate that atopic-wheeze and aeroatopic-wheeze from the fifth
year-of-life are well-defined endotypes in their own right.
Substituting in the AUCs scored by second-year (log of) house-dust-mite IgE for
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= .49± .05. (3.13)
confirming that atopic-wheeze is a well-defined endotype of wheeze. The result is similar







= .48± .04. (3.14)
Consistency requires that aeroatopic-wheeze be an endotype of atopic-wheeze. Substi-







= .60± .13, (3.15)
as required, although the errors are substantially larger in this example.
In subsection 3.2.2 we found that atopy-number in the first year-of-life scored AUCs
of .66 and .80 predicting fifth-year wheeze and aeroatopic-wheeze, respectively. Substi-








The corresponding equation for the atopic-wheeze endotype does not hold, with first-
year atopy-number predicting fifth-year atopic-wheeze scoring the same AUC as aeroatopic-
wheeze despite a different number of cases. Atopy-number from the second year-of-life,
by contrast, obeys equation (3.1) for all combinations of wheeze, atopic-wheeze and
aeroatopic-wheeze, as indicated in table 3.1. This was unexpected as the first-year
predictor was the better predictor of atopic-wheeze.
We have calculated the exclusivity to atopic-wheeze and aeroatopic-wheeze of several
good predictors, and presented them in table 3.1. Not surprisingly, (log of) house-
dust-mite IgE is also an exclusive predictor in the first year-of-life. Another exclusive
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response atopy predictor allergens AUC p-value nb. cases
cat (log) dust-mite .94 2.2× 10−7 9
peanut (log) dust-mite .96 9.7× 10−9 10
couch (log) dust-mite .97 1.3× 10−11 14
rye (log) dust-mite .93 1.7× 10−11 16
cat/peanut/couch/rye (log) dust-mite .94 7.8× 10−14 20
mould mould .78 1.2× 10−6 7
mould mould (year 3) .90 2.4× 10−9 7
mould & dust-mite (log) mould and dust-mite .94 < 2.4× 10−9 5
dust-mite (log) dust-mite .81 3.8× 10−10 28
dust-mite (log) dust-mite, febrile-LRI .85 < 3.8× 10−10 28
Table 3.5: Predictors of atopic-wheeze endotypes from IgE data: Predictors
taken from second year of life unless indicated otherwise. p-value is found from the
Mann-Whitney U -test for single predictors.
response atopy wheeze atopic-wheeze aeroatopic-wheeze
cat .62 ±.02 .70 ±.02 .73 ±.02
peanut .61 ±.02 .68 ±.02 .71 ±.02
couch .57 ±.02 .62 ±.03 .63 ±.03
rye .57 ±.02 .62 ±.03 .63 ±.04
cat/peanut/couch/rye .52 ±.03 .52 ±.04 .49 ±.05
house-dust-mite .53 ±.03 .56 ±.09 .51 ±.29
mould (second year-of-life mould -IgE ) .46 ±.02 .48 ±.02 .44 ±.02
mould (third year-of-life mould -IgE ) .51 ±.02 .52 ±.02 .55 ±.02
Table 3.6: Exclusivity index of (log of) house-dust-mite IgE in the second
year-of-life for various allergen-specific atopic-wheezes.
predictor is atopy-number, though only in the second year-of-life. Febrile- and severe-
LRI s are not exclusive to atopic-wheeze despite their efficacy in predicting it.
3.4 New asthma endotypes, characterised by their atopic triggers
The CAS data set includes neither neutrophilic nor eosinophilic data, but we obtained
very encouraging predictor scores by considering atopy to specific allergens. Cat, peanut,
couch and rye were particularly well-predicted, with AUCs greater than .9. As a guard
against the small number of cases we also found the significance of each AUC using
the Mann-Whitney U -test. These p-values are included in table 3.5 and range from
1.2× 10−6 to 7.8× 10−14.
Calculating the exclusivity index from equation (3.5) for each of these allergen-
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specific endotypes found three smaller endotypes with exclusive predictors, as shown in
table 3.6. These were wheeze with mould -related atopy, wheeze with house-dust-mite
related atopy , and atopic-wheeze where the atopic allergens include at least one of cat,
peanut, couch or rye. (We observed that participants with atopic-wheeze sensitized to
one or more of these allergens in the fifth year-of-life were also atopic to house-dust-
mite.) We call this last case multi-allergen atopic-wheeze. The first was exclusively
predicted as an endotype of both wheeze and atopic-wheeze by mould -IgE in the third
year-of-life. However it was not found to be an exclusive endotype of aeroatopic-wheeze,
which it logically should be given that mould is an airborne allergen. Plausible expla-
nations for this include statistical noise due to the small number of cases, and cases of
mould -related atopic-wheeze strongly coinciding with some more relevant factor. Hence
some uncertainty remains concerning the nature of this endotype.
The other two of the smaller endotypes above were exclusively predicted by (log
of) house-dust-mite IgE in the second year-of-life. Furthermore, multi-allergen atopic-
wheeze as an endotype of house-dust-mite atopic-wheeze scored an exclusivity index of
.485.
So not only is predictive ability of house-dust-mite IgE limited to aeroatopic-wheeze,
but to the even more specific endotype of multi-allergen atopic-wheeze. In particular,
it has no predictive power for aeroatopic-wheeze where the allergens do not include at
least one of rye, couch, cat or peanut.
3.5 Outcomes
While the ability to predict wheeze, our proxy for asthma, in the fifth year-of-life from
data from the first two years-of-life, was strongly limited by overfitting, it was readily
apparent that even linear classifiers with single or few predictors could further illumi-
nate the nature of asthma. The literature has begun to acknowledge [15, 168–170] the
importance of asthma endotypes, and their having different predictors is no real sur-
prise. We only considered conditions which could be readily described in terms of CAS
variables, such as the presence or absence of atopy or specific atopic sensitivities. Since
44 Chapter 3: Asthma endotypes from early-life prediction
such definitions are trivial to compose we required the existence of at least one exclu-
sive predictor before claiming that such a definition had any biological meaning. We
were able to identify endotypically exclusive predictors with quantitative relationships
to more general cases. One of the best-known predictors of asthma, house-dust-mite IgE
in the second year-of-life, was found to be truly predictive of only a specific endotype
of atopic-wheeze. This multi-allergen endotype is one of the most common, and the
apparent predictivity of second year house-dust-mite IgE of atopic-wheeze and wheeze
in general was attributable to its proportion of cases in atopic-wheeze, and of atopic-
wheeze in the wheeze cases of CAS. We did attempt a similar study of atopic-wheeze
where house-dust-mite was the only atopic allergen, but were stopped by a lack of
statistical power.
Seen in this light, exclusive predictors of other endotypes, such as non-atopic wheeze,
are less predictive for wheeze in general, but are equally important in understanding
the bigger asthma picture. We therefore needed to consider the exclusivity of such
predictors and their predictive power for the relevant endotype, without being distracted
by the possibly low AUC for wheeze in general. This was facilitated by the exclusivity
indices in equations (3.5, 3.6), which are, to within a calculable error margin, equal
to one half when the endotype is exclusively predicted within the more general case.
Unfortunately this does not solve the problems associated with insufficient sample size,
its best contribution to that particular problem being a stronger, quantitative, argument
for future detailed studies.
This multi-allergen atopic-wheeze will feature in the next chapter in our discussion
of the infant NP microbiome. For now we conclude this chapter with a list of its specific
important outcomes:
1. That the number of allergens to which the child is atopic in the first year-of-life
is an excellent predictor of atopic-wheeze, better even than second-year (log of)
house-dust-mite IgE, neither of which have any predictive power for any form of
nonatopic-wheeze.
§3.5 Outcomes 45
2. Equations (3.1) to (3.6) relate the AUCs scored by a predictor for the general case
and for one of its specific endotypes. Equations (3.5) and (3.6) in particular give
a measure of exclusivity which does not reflect the AUC itself.
3. That the predictive ability of second-year (log of) house-dust-mite IgE for wheeze
in the fifth year-of-life is exclusive to not just atopic-wheeze or even aeroatopic-
wheeze, but to atopic-wheeze with at least one of peanut, cat, couch and rye
included among the atopic allergens. (Such atopics in the fifth year-of-life always
include house-dust-mite among their atopic allergens as well.) This endotype
contained no exclusive smaller one that we could find.
4. That the number of older children in the house, both at birth and in the second
year-of-life, were exclusive predictors of nonatopic-wheeze in the fifth year-of-life.
5. That some important predictors, including severe-LRI and febrile-LRI , are not
exclusive to either atopic- or non-atopic- wheeze but are predictive of both.
6. That the AUCs of predictors exclusive to separate endotypes simply add (minus
.5) when they are combined in a set predicting the common general condition
(equation (3.3)). The obvious examples of this are predictors sets of atopic- and
non-atopic- wheeze combining to predict wheeze, examples of which are given in
tables 3.3 and 3.4.
7. That mould -IgE from the third year-of-life exclusively predicted (AUC of .90)
wheeze with atopy to mould in the fifth year-of-life, as endotypes of both fifth-
year wheeze and fifth-year atopic-wheeze, but not of aeroatopic-wheeze. We cannot
determine if this last anomoly is due to statistical noise (there were only seven




The early nasopharyngeal microbiome
and later (atopic) wheeze status
4.1 Introduction
There has long been a strong association between asthma development and respiratory,
especially viral, infections during infancy [6,48,51,52], and mounting evidence [7,86,171]
for an association with the nasopharyngeal (NP) microbiome in early infancy. The CAS
cohort therefore included detailed microbiome and virus data from NP microbiome sam-
ples taken at various time-points [5, 6, 19]. The genera typically found in the NP mi-
crobiome are Alloiococcus, Streptococcus, Staphylococcus, Haemophilus, Moraxella and
Corynebacterium [7].
We sought to go beyond conventional linear analysis, with Teo et al. [7] having
already found correlation between Streptococcus and fifth-year wheeze. We were also
interested in whether inter-genus interaction might be of comparable importance to
any specific genera. We addressed these questions with dual qq-plots, in which we
compared qq-plots generated for case and control samples on the same axes. The
signals we observed required no such interaction, but we did observe some genera to be
of relevance to later wheeze and atopy under certain circumstances.
The work of Teo et al. [7] found that samples taken during the course of an acute
respiratory infection, or ARI samples, have different associations from those taken in
the absence of a respiratory infection, or non-ARI samples. We therefore considered
ARI and non-ARI samples separately. We would have liked to restrict our analyses
to the first seven weeks-of-life, but limited statistical power meant that we could only
do this for non-ARI samples so we were forced to consider ARI samples from the
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first 90 days-of-life. We found that the relative abundances of some genera in the NP
microbiome from these data sets were predictive of some fifth-year outcomes.
Subsection 4.2.1 in particular demonstrates that Haemophilus,Moraxella and Staphy-
lococcus relative abundances during respiratory infections in the first 90 days-of-life
affect later wheeze and atopy status. In section 4.2.2 we confirm the importance of
Streptococcus to fifth-year wheeze status [7].
Section 3.4 identified the multi-allergen atopic-wheeze endotype, and in section 4.3
we find that Streptococcus relative abundance in non-ARI samples from the first seven
weeks-of-life to be predictive of it. The sample sizes in this data set are very small, but
the Mann-Whitney U -test still found the predictive power significant (p-value < .05).
Finally, a detailed extraction of how the relative abundances were obtained is pro-
vided in appendix F.
4.2 Inference of predictor and genera interaction from dual qq-plots
4.2.1 Results from ARI-data in the first 90 days-of-life
We found that restriction to seven-week ARI samples had insufficient statistical power
to generate useful dual qq-plots, so we used ARI -samples from the first 90 days-of-life.
We also sought further support for important genera by testing their ability to predict
their associated outcome. Such a test is prone to false negatives because of its linearity
assumptions, but it is gratifying when such a signal is found. Microbiome samples were
taken with every respiratory infection, so some individuals contributed multiple ARI
samples from the first 90 days-of-life. We dealt with this issue by using the h-block
cross-validation [172]. This was not a consideration for non-ARI samples from the first
seven weeks-of-life because no individual gave more than one such sample.
Haemophilus in ARI -samples is associated with increased risk of wheeze via
a non-atopic mechanism
Figure 4.2 indicates that the ARI samples of those who go on to exhibit wheeze in the
fifth year-of-life are associated with higher relative abundances of Haemophilus. The
corresponding result is less clear for the specific fifth-year endotype atopic-wheeze (figure
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E.1) but is stronger for nonatopic-wheeze (figure 4.3). This associates Haemophilus
with a non-atopic mechanism of wheeze, although we cannot comment on whether it is
actually causal.
Moraxella in ARI -samples is associated with a decreased risk of atopic-
wheeze in the fifth year-of-life
The dual qq-plots in figure 4.4 show an apparently protective effect of Moraxella against
atopic-wheeze, where those who developed fifth-year atopic-wheeze were associated with
lower relative abundances of Moraxella. This held to a lesser extent for wheeze, as
shown in figure E.2 but not for those who went on to develop fifth-year nonatopic-
wheeze, for whom the relative abundance of Moraxella is higher than for those who did
not (see figure 4.5). We cannot determine if Moraxella relative abundance actually led
to nonatopic-wheeze, which seems unlikely given its association with reduced wheeze
risk, but it follows that it was associated with lowered risk for atopic-wheeze.
Moraxella from these samples was a statistically significant predictor of nonatopic-
wheeze in the fifth year-of-life using logistic regression, with an AUC of .60 and a
Mann-Whitney p-value of .01.
Staphylococcus in ARI -samples is associated with an increased risk of atopic-
wheeze in the fifth year-of-life
The reverse is true for Staphylococcus, which represents a decreased risk relative to all
other genera for nonatopic-wheeze (figure 4.6), but an increased risk for atopic-wheeze
(figure 4.7). On the other hand, figure 4.1 shows that while a relatively high rela-
tive abundance of Staphylococcus in ARI samples taken during the first year-of-life
(a functional cutoff would be 0.1) appears to protect against nonatopic-wheeze in the
fifth year-of-life, the counter-examples all came from a specific individual who later
submitted four other ARI samples in which the relative abundances of Staphylococcus
were well below this cutoff. This is not consistent with elevated Staphylococcus actively
contributing to atopic-wheeze in the fifth year-of-life and suggests an indicative rela-
tionship, although it is also possible that some other factor has arrested the pathogenic
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Nonatopic wheeze year 5
No nonatopic wheeze year 5
Individual XX
Figure 4.1: Relative abundance of Staphylococcus in biome samples taken from
participants during a respiratory infection in the first year-of-life. Samples
with a high relative abundance of Staphylococcus did not come from those
who later exhibited nonatopic-wheeze in the fifth year-of-life, with two ex-
ceptions whose common donor, whose samples are labelled XX in the plot,
later yielded ARI samples with low relative abundances of Staphylococcus,
suggesting the relationship is probably indicative: Since Staphylococcus in early
(90 days) ARI samples was a risk factor for atopic-wheeze in the fifth year-of-life, we
conclude that it was not so much protective as associated with the atopic asthma en-
dotype instead.
process.
We are reminded of Barnes’ suggestion [28] that non-allergic asthma might be driven
by so-called superantigens produced by Staphylococcus and similar microbes, but our
results indicate that Staphylococcus, at least when accompanied by respiratory infection,
is a risk for atopic-wheeze instead.
§4.2 Inference of predictor and genera interaction from dual qq-plots 51
NP genus wheeze atopic-wheeze nonatopic-wheeze
Streptococcus .043 .016 .953
Streptococcus and
Haemophilus .044 .015 .958
Table 4.1: Mann-Whitney p-values of wheeze dependence on the relative abun-
dance of Streptococcus in non-ARI samples taken during the first seven
weeks-of-life (logistic regression). We considered two classes of model, one in
which only Streptococcus was considered and one in which Haemophilus was considered
also.
Both fifth-year nonatopic-wheeze and atopic-wheeze were predicted with the logistic
regression classifiers, scoring AUCs of .67 and .66, respectively. (The AUC was .65 for
both endotypes using the naïve Bayes classifier.) The AUC was significant only for
atopic-wheeze with a Mann-Whitney p-value ≈ .03.
4.2.2 Fifth-year wheeze from 7-week non-ARI data
The dual qq-plots in figure 4.8 confirm that samples from participants who go on to
exhibit wheeze in the fifth year-of-life are associated with higher relative abundances
of Streptococcus. This is at the expense of every other genus except Haemophilus.
Although these signals look significant to the eye, we quantified their significance where
we could. We used logistic regression to model the dependence of wheeze in the fifth
year-of-life on the relative abundance of Streptococcus and other genera. It was not
appropriate to include the relative abundances of all genera, since they are constrained
to sum to one, so we found two models, one with Streptococcus only and another that
also included Haemophilus. We considered Haemophilus because it is the only genus
for which figure 4.8 shows no antagonism with Streptococcus . The results are shown in
table 4.1. Unlike the dual qq-plots there is a stronger signal for atopic-wheeze than for
wheeze in general, associating Streptococcus in these samples with an atopic mechanism.
While the calculated significance is only marginal, it is reasonable to consider this an
underestimate of significance since logistic regression assumes a log-linear relationship,
which is a poor assumption in this case. Values for Haemophilus are not shown as it
was never found to have a significant coefficient.
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4.3 Prediction of allergen-specific atopic-wheeze from microbiome rel-
ative abundance in infant microbiome data
To see if the microbiome relative abundances were endotype-specific we studied their
predictive power for allergen-specific atopic-wheeze in the fifth year-of-life. We found
some suggestive results for Streptococcus, though we lacked the statistical power to make
any definitive claims.
The relative abundance of Streptococcus in non-ARI samples from the first seven-
weeks of life scored an AUC of .60 from both classifiers predicting fifth-year atopic-
wheeze, but scored AUCs in the mid-to-high 80% range, predicting almost all of the
allergen-specific atopic-wheeze endotypes identified in chapter 3. The exception was
rye-specific atopic-wheeze whose predictivity was not statistically significant. The cor-
responding AUCs and p-values are presented in table 4.2. (The AUCs given in this
chapter were calculated using logistic regression, however naïve Bayes gave the exact
same AUCs for all cases in this chapter except for prediction of multi-allergenic atopic-
wheeze by Streptococcus relative abundance in non-ARI samples from the first seven
weeks-of-life. In this the naïve Bayes classifier scored less than logistic regression by
.025)
While the multi-allergen endotype was also well-predicted (AUC=.76), the poor
prediction of rye-specific atopic-wheeze prompted us to consider a reduced form where
rye was not included. While this did score an improved AUC of .83, the result is hardly
surprising and the exclusivity index from equation (3.5) was .58 ± .02, which does not
support an exclusive subtype. In case this was due to the limited statistical power of
the microbiome samples we repeated the calculation using (log of) house-dust-mite IgE
from the second year-of-life and again found no evidence, scoring an index value of
.76 ± .19. (For the interested reader, the corresponding AUC was .96 instead of .94,
with an identical p-value of 7.8× 10−14 from a smaller number (18) of cases.)
The relevant p-values (table 4.2) are less than .05 but not overwhelmingly so. Even
if the significance cutoff did not need to be adjusted for six genera and six relevant
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response atopy AUC p-value nb. cases
cat .84 .024 5
peanut .87 .035 3
couch .89 .007 4
rye .66 .15 6
cat/peanut/couch/rye .76 .022 8
cat/peanut/couch .83 .006 7
house-dust-mite .62 .19 11
Table 4.2: AUCs of atopic-wheeze endotypes from the relative abundance
of Streptococcus in 7-week non-infectious microbiome samples: The relative
predictability of the specific atopies is consistent with Streptococcus being exclusively
predictive of the multi-allergen endotype identified in section 3.4, except for rye. The
sample sizes were very small, as indicated, and combined with the overtesting issues
discussed in the text, we present this as a strong hint for Streptococcus being exclusively
predictive of this endotype, but lack the statistical power to claim this as a result. Again,
p-value is found from the Mann-Whitney test.
allergens (house-dust-mite, peanut, mould, couch, rye and cat), the corresponding sample
sizes would not allow us to confidently identify an endotype on this basis. We simply
wish to note that the AUCs are strongly suggestive of Streptococcus being relevant to
at least some cases of the multi-allergen endotype inferred from the exclusivity index
(equation (3.5)) in section 3.4. This must remain a suggestion for now as we lack the
statistical power to take it further.
4.4 Outcomes
The relevance of the NP microbiome to wheeze and early infection had already been
demonstrated by [7]. In this chapter we have used dual qq-plots to demonstrate new
associations with later wheeze endotypes, and to provide additional detail on the asso-
ciation of Streptococcus in non-ARI biome samples and wheeze in the fifth year-of-life.
Questions concerning causality remain. None of the associated genera seem to be nec-
essary or sufficient, so it is not clear that they are actually causal. Tools such as Pearl’s
causal calculus [101] can sometimes shed light on such questions but that is beyond the
scope of this work. Nonetheless, we may still conclude that at least some causal factors
are manifest at this very early time of life. A summary of this chapter’s outcomes is as
follows:
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1. The relative abundance of Haemophilus in ARI microbiome samples during the
first 90 days-of-life was associated with wheeze in the fifth year-of-life via a non-
atopic mechanism. This was not detectable with a logistic regression model.
2. The relative abundance of Moraxella in ARI microbiome samples during the first
90 days-of-life was associated with a reduced risk of wheeze and especially atopic-
wheeze in the fifth year-of-life, but a greater risk of nonatopic-wheeze. This last
association was also detected by a logistic regression classifier.
3. The relative abundance of Staphylococcus in ARI microbiome samples during the
first 90 days-of-life was the converse of Moraxella, with greater risk of wheeze
and atopic-wheeze and a reduced risk of nonatopic-wheeze. This would indicate a
fifth-year wheeze risk via an atopic mechanism.
4. The above associations of Staphylococcus are most likely indicative, since the in-
dividual who developed nonatopic-wheeze in the fifth year-of-life after donating
(two) ARI samples with high relative abundances of Staphylococcus, submitted
later ones with low relative abundances of Staphylococcus.
5. The relative abundance of Streptococcus in non-ARI microbiome samples during
the first seven weeks-of-life was associated with greater risk of wheeze in the fifth
year-of-life according to the dual qq-plots. This effect was detectable by logistic
regression, which also detected an increased risk of fifth-year atopy with greater
significance. However the corresponding effect on atopic-wheeze is not visible in
the dual qq-plots.
6. The relative abundance of Streptococcus in non-ARI microbiome samples during
the first seven weeks-of-life was scored relatively high AUCs for almost the same
allergen-specific atopic-wheeze that (log of) house-dust-mite IgE from the second
year-of-life was predictive of. The exception was rye-specific atopic-wheeze, but
the exclusivity index did not find this to be indicative of a more precise endotype.
It is suggestive of Streptococcus in these samples being important formulti-allergen
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atopic-wheeze, but we concede that there is insufficient statistical power to make
a definitive claim.
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Figure 4.2: QQ-plots demonstrating a link between an elevated relative abun-
dance of Haemophilus in biomes from the first 90 days-of-life when the






























+ve fifth-year non-atopic wheeze
-ve fifth-year non-atopic wheeze
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+ve fifth-year non-atopic wheeze
-ve fifth-year non-atopic wheeze
Figure 4.3: QQ-plots demonstrating the link between an elevated relative
abundance of Haemophilus in ARI biomes from the first 90 days-of-life,
and nonatopic-wheeze in the fifth year-of-life:
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Figure 4.4: QQ-plots demonstrating a link between an elevated relative abun-
dance of Moraxella in biomes from the first 90 days-of-life when the partic-
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+ve fifth-year non-atopic wheeze
-ve fifth-year non-atopic wheeze
(c)



























+ve fifth-year non-atopic wheeze
-ve fifth-year non-atopic wheeze
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+ve fifth-year non-atopic wheeze
-ve fifth-year non-atopic wheeze
Figure 4.5: QQ-plots of the relative abundance of Moraxella compared to
other genera, where we distinguish between samples that are postive or
negative for nonatopic-wheeze in the fifth year-of-life: The protective effect
observed against atopic-wheeze in figure 4.4 is absent.
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Figure 4.6: QQ-plots demonstrating a link between an elevated relative abun-
dance of Staphylococcus in biomes from samples taken during the first 90
days-of-life when the participant was suffering a respiratory infection, and
lack of nonatopic-wheeze in the fifth year-of-life:
§4.4 Outcomes 61
(a)


























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze
(b)



























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze
(c)


























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze
(d)

























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze
(e)




























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze
Given the protective effect against
nonatopic-wheeze in the fifth year-
of-life, seen in figure 4.6, we con-
clude that Staphylococcus in ARI
samples is a risk factor for atopy
leading to wheeze.
Figure 4.7: QQ-plots demonstrating a link between an elevated relative abun-
dance of Staphylococcus in biomes from the first 90 days-of-life when the
participant was suffering a respiratory infection, and atopic-wheeze in the
fifth year-of-life:
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Figure 4.8: QQ-plots demonstrating a link between an elevated relative abun-
dance of Streptococcus during the first seven weeks-of-life in biome samples
taken when the participant was free of respiratory infection, and wheeze in
the fifth year-of-life:
Chapter 5
Inferred dynamic Bayesian networks
5.1 Introduction
We have seen that the causes and aetiology of asthma are complicated. In chapter 3
we saw that important factors sufficient to define a biological endotype of wheeze may
well be restricted in their relevance to such a small minority of asthma cases that their
predictive ability for the general condition is swamped by noise. As such they cannot
be used by simple methods being applied to predictions of wheeze. In chapter 4 we saw
that at least some causal factors are present even in the first seven weeks-of-life. The
many variables of asthma pathogenesis require non-trivial networks to understand the
interactions amongst them.
We chose our network variables to address questions relevant to the current state
of the field, often beginning with general variables, say LRI, before moving on to more
specific variables, such as mild - and severe- LRI. Much of our effort was spent studying
networks of infection, wheeze and atopy. We also found interesting networks among
IgE s and interleukins.
5.2 Technical considerations concerning our inference of dynamic Bayesian
networks
Rather than reinvent the wheel, we used the ARTIVA package, originally created to infer
genetic interaction networks [8], to generate our DBNs. We have already described how
ARTIVA works in our review of Bayesian networks (subsection 2.2.1). In this section we
discuss our handling of the technical issues. Since Lebre et al. discuss the technicalities
of ARTIVA quite thoroughly, we largely accept their default parameters, including the
number of iterations, for which their default was 50,000, more than enough for the
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RJ-MCMC algorithm to “burn-in” [8]. We allowed the maximum possible number of
changepoints, which was one less than the number of time-points. We set edgesThreshold
to .4 and took the default values for the other input variables. We used R version 3.1.1.
Unfortunately ARTIVA is no longer maintained by its authors so care must be taken in
upgrading to a more recent version of R.
5.2.1 Independence approximation and choice of variables
The ARTIVA algorithm assumes that all parent nodes are independent. Since many
of the variables are confounding simply by virtue of their relevance to asthma, it was
impossible to ensure that this was even approximately true in many of our networks.
Although Bayesian methods have often been found to tolerate the violation of this
assumption remarkably well [124–126], this was nonetheless a strong incentive to avoid
overly large networks and instead choose networks of specific variables to address specific
questions.
For this reason we also chose variables whose definitions did not overlap. For ex-
ample, we have avoided including severe-LRI with either wheezy-LRI or febrile-LRI
because the latter two are special cases of the first, although we sometimes commit
minor violations of this rule since wheezy-LRI and febrile-LRI share an overlap. This
was generally not a problem but some networks were improved by distinguishing the
purely febrile or wheezy infections from those that were both (e.g. see figure 5.22).
Conversely, since we wish to ascertain which specific variables are relevant, it was
also appropriate to cover all subtypes of a given variable, and not just the ones for which
we expected an effect. For example, in figure 5.15 when we expected wheezy-LRI to be
the only severe-LRI s that interacted we still included febrile-LRI to be sure that the set
was covered. Another illustrative example is figure 5.18, where we included severe-LRI
with nonairborne-atopy when considering the importance of accompanying severe-LRI
with atopy but wanted to focus on airborne-atopy.
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5.2.2 Augmented discrete variables in Gaussian process priors
As explained in the review of Bayesian methods 2.2, ARTIVA’s Gaussian prior is ill-
suited for discrete data. Since some of CAS’ most important data, such as infection
count data and multiple binary variables are discrete, we implemented a much-cited
solution first proposed by Albert and Chibb [9], in which discrete data are augmented
by latent variables which are sampled from truncated Gaussian distributions just as the
linear coefficients are.
Since this procedure need only be applied to data at the child nodes, and ARTIVA
works by inferring parents for each child, it was straightforward to do this consistently.
We also used the fact that the discrete data was either count or binary data to simplify
Albert and Chib’s procedure. The complete procedure for arbitrary discrete data in-
cludes a step in which the cutoffs between discrete categories are also sampled [9]. This
is necessary for categorical data in general because the integer labelling of categories is
entirely arbitrary. This is not so for the special case of count data however, because the
categories “zero”, “one”, “two” etc. meaningfully correspond to the integer values 0, 1, 2
etc., allowing us to neglect this step.
Our implementation is contained in a module which is called from within ARTIVA’s
module “main.R”. The code is available by request from the author at
m.walker@aip.org.au .
5.2.3 How we rendered our networks
The layout of our DBNs
The graphs representing each network have one node for each variable at each time-
point. These are laid out in a grid. The rows correspond to the variables listed along
the y-axis, while the columns correspond to the time-periods, usually the first to the
fifth years-of-life, although some networks show data at six months or at birth (from
cord blood), labelled by “6m” and “birth” respectively.
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The effect strength (width) and sign (dashed is negative) associated with
edges
The presence of an edge indicates that the value of the child node varies (approximately)
linearly with that of the parent node. The width is proportional to the corresponding
linear coefficient, with solid lines indicating a positive coefficient and dashed lines in-
dicating a negative coefficient. We describe this in the text by saying that a parent
variable led to a child variable if there is solid edge connecting the corresponding nodes,
and that it led against if the effect is a negative one (dashed line). If a variable led to
itself from one year to the next we describe it as ongoing. We also capped the width of
the lines at two in order to keep the graphs legible.
The posterior probability of an edge determines its shade
As discussed above, ARTIVA returns the posterior probability of each edge which we
found to be valuable in identifying appropriate variable choices and subsets. While all
edges are coloured black, their opacity fades with decreasing posterior, with the α-value
equal to the edge’s posterior.
When discussing the DBNs in the text, we often refer to variables acting on each
other with a high, intermediate or low posterior (probability), and this corresponds
to edges drawn in black or medium to light shades of grey. A legend showing the
correspondence between shade and posterior probability is given in appendix G.
We shall argue in the following two subsections that edges with intermediate pos-
terior indicate either a statistical limitation or that the relationship applies to only a
subset of participants/events. We therefore used such grey lines to infer combinations
of variables that are of more direct relevance, effectively allowing the data to guide us
to better choices of variables.
Nodes corresponding to non-longitudinal data
Not all of the CAS variables were longitudinal. An important example of this was
transient wheeze, a binary variable whose positive value indicated that wheeze was
present in at least one of the first three years-of-life but absent in the fifth. Others
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were one-off measurements, typically peri-natal. These included measures of breast
milk fatty acid or protein content. Another example is the number of older siblings in
the house at birth, found to be slightly predictive of fifth-year nonatopic-wheeze status
in subsection 3.2.3.
Causality clearly requires that variables from the fifth year-of-life can only be child
nodes. However, they might be particularly dependent on early-life data, say from the
first two years-of-life. We were able to test for this by replicating these variables at
multiple time points and instructing ARTIVA to only consider them as child nodes and
never as parent ones. The child-only nodes of value to us were transient wheeze, whose
definition includes fifth-year data, and wheeze in the fifth year-of-life. Child-only nodes
do not appear in the first time-step interval of any graph, and are rendered in blue as
a visual aid. The converse was true for peri-natal variables, which could only be parent
nodes but might lead to later variables indirectly. We also had the capacity to replicate
these variables at every time-step, but found no useful DBNs this way.
5.2.4 The effect of missing data
Missing data are to be expected in a longitudinal cohort study the size of CAS but
ARTIVA does not tolerate missing data in its input, its creators having access to com-
plete data sets [8]. This required us to either impute the missing data or restrict
ourselves to complete records.
Mean imputation allowed us to retain more individuals, leaving us with greater
statistical power for the variables that were not missing, but compromised sensitivity
for those variables that did have a significant amount of missing data. Conversely,
restriction to individuals for which none of the specified variables had no missing data
allowed greater sensitivity for variables for which the data was missing for a significant
number of individuals, but sometimes at the cost of weakening detection for other
variables for which much less data was missing. The restriction approach also had
the effect of restricting the number of variables in the networks, since each additional
variable brought the risk of more missing data removing more individuals.
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Figure 5.1: DBN of atopy, wheeze, LRI and URI in which the missing data
was mean-imputed: There is a fading of edges leading to both URI and LRI in
the fifth year-of-life. Otherwise, all four conditions appear to have been ongoing, with
wheeze leading to LRI for the first three years-of-life. The same is true of atopy, though
with only an intermediate posterior. This should be compared with figure 5.2.
The other problem with mean imputation is that it was incompatible with binary
and count data, simply because the mean of such data is effectively never integral.
Rounding off to the nearest integral was a potential source of error, giving us more
reason to favour discarding individuals with missing data.
These issues are well illustrated by networks of general infection data. CAS had
a lot of missing infection data, especially from the fourth and fifth years-of-life. The
number of participants yielding LRI and URI data from the first to the fifth years-of-
life was 194, 195, 189, 166 and 140, respectively. (This discussion is simplified by an
exact correspondence between the participants lacking LRI data and those lacking URI
data in any given year-of-life.)
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Figure 5.2: DBN of atopy, wheeze, LRI and URI for which only complete
records were used: LRI does not show the same fading in the fifth year-of-life which
was observed in figure 5.1. There is an additional edge to fifth-year LRI from atopy.
On the other hand, earlier edges to LRI from wheeze and atopy are now missing.
We inferred two DBNs from URI, LRI, atopy and wheeze, one with mean-imputation
and one by restriction to individuals whose records are complete in those variables.
These networks are shown in figures 5.1 and 5.2, respectively. The number of data
points available to infer an edge between the first pair (years one and two), second pair
(years two and three), etc. finds sample sizes of 187, 183, 158, and 127 respectively. Since
the overlap between these sets is imperfect, requiring all individuals to have complete
data in these variables reduces the sample size to 97. Combined wheeze and atopy data,
by contrast, suffer a much smaller attrition, with year-to-year sample sizes of 204, 202,
200, 186 and 169.
The DBN resulting from mean-imputation, shown in figure 5.1, indicates a fainter
edge in the LRI row between the fourth and fifth years-of-life in comparison to earlier
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Figure 5.3: DBN from replacing atopy with airborne-atopy in figure 5.1: Edges
from airborne-atopy are darker in this DBN than the corresponding edges from atopy
in that of figure 5.1. This led us to the conclusion that airborne-atopy is a better choice
of variable than atopy .
edges (legend in appendix G). The network inferred using only data from the 97 indi-
viduals with complete data for all four variables across all five years is shown in figure
5.2. The lower posteriors for the edges indicating the effects of atopy and wheeze are
lower. In fact, the edges to LRI from wheeze and atopy during the first four years-of-life
have vanished. Also, the edges connecting URI - and LRI - related nodes are unchanged
except for that connecting the sequential URI nodes in the fourth and fifth years-of-life.
That edge is now as dark and thick as the corresponding edges for earlier timepoints.
This suggests that susceptibility to URI does not change going into the fifth year-of-life.
So mean-imputing missing data appears to ‘wash-out’ the corresponding signal, but
protects connections with well-populated variables. The reader might question whether
statistically meaningful results can truly be found from the smaller data set, but we have
just seen that statistical uncertainty lowers the edges’ posterior making false positives
unlikely. It is worth remembering that the original application of ARTIVA generated
networks from only ten samples [8].
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Figure 5.4: DBN from replacing atopy with airborne-atopy in figure 5.2: Sim-
ilarly to figure 5.3, edges from airborne-atopy are darker in this DBN than the corre-
sponding edges from atopy in that of figure 5.2. This again indicates that airborne-atopy
is more important than nonairborne-atopy, and a better choice of variable than atopy .
Our approach was therefore to discard incomplete records for any given network,
although the corresponding mean-imputed networks for infection variables sampled over
five years are given in appendix H. The differences were typically small and similar in
nature to the ones we have just discussed.
5.2.5 The meaning of intermediate posteriors
Some of the inferred networks have edges of intermediate posterior even when the cor-
responding data are not missing. Sometimes these edges are quite wide, indicating the
inferred effect to be relatively large. Given sufficient statistical power, it is reasonable to
attribute the reduced posterior to another ‘wash-out’ effect, due not to mean-imputed
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Figure 5.5: Atopy with wheeze led to chronic (fifth-year) wheeze. Only wheeze
without atopy could be transient. Atopic conditions were ongoing, wheeze
without atopy less so: Atopy without wheeze leads to atopy with wheeze. Unlike
figure 5.6, there is also a faint edge going back.
missing data, but to the effect in question only being relevant to a subset of the events,
such as particular types of a given infection, special cases of atopy etc. This is illustrated
by comparing figures 5.3 and 5.4 to figures 5.1 and 5.2, respectively. We see edges lead-
ing to LRI , especially from atopy or airborne-atopy, have a higher posterior in the latter
two figures than in the former two. In fact, edges from atopy to LRI vanish in figure
5.2. Since airborne-atopy is a subset of atopy, we take this to mean that the effect of
atopy in these figures is due, or at least stronger for, the airborne-atopy subtype. The
lower posterior results for atopy can then be attributed to a sort of wash-out effect
where only a subtype (airborne-atopy in this case) contributes while its complement
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predictor year-of-life
1 2 3 4
wheeze with airborne-atopy 9.26× 10−3 8.48× 10−4 2.87× 10−9 1.07× 10−7
wheeze without airborne-atopy .804 .343 .076 2.99× 10−4
Table 5.1: χ-squared test of airborne-atopy acting on fifth-year wheeze. Consistent
with figure 5.6, the presence of airborne-atopy significantly increases the probability of
wheeze persisting to the fifth year-of-life.
predictor year-of-life
1 2 3 4
wheeze with airborne-atopy .818 .806 .186 .069
wheeze without airborne-atopy 2.95× 10−7 1.32× 10−3 .011 .921
Table 5.2: χ-squared test of airborne-atopy leading to transient wheeze. Consistent
with figure 5.6, the presence of airborne-atopy significantly decreases the probability of
wheeze being transient.
(nonairborne-atopy) does not.
As a guard against hidden random effects, and to positively identify the relevant
subtypes, such interpretations should be verified with a new network in which the
subtypes of interest may be distinguished.
5.2.6 Independent testing of inferred edges with the χ-squared test
Bayesian approaches are adept at ignoring irrelevant data [113, 115], and are generally
disinclined to find false relationships [114]. They also cope well with missing data [112],
generally speaking. Taken together, these points indicate that while random effects such
as biases in the missing data might conceivably weaken the apparent significance of a
variable and/or one of its subsets, it would be highly unlikely to exaggerate the relevance
of the complementary subtype. We have also already noted at the end of subsection 5.2.4
the generally low insensitivity of our infection-related networks to whether incomplete
records are deleted or their missing data imputed. Nonetheless, we cannot assume
flawless output from real-world data, so we also verified our important edges with the
χ-squared test.
The χ-squared test and the ARTIVA algorithm, though reasonably consistent with
each other, do not agree exactly. This is to be expected, since they are different models
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Figure 5.6: Airborne-atopy with wheeze led to chronic (fifth-year) wheeze.
Only wheeze without airborne-atopy could be transient. Atopic conditions
were ongoing, wheeze without airborne-atopy less so: Airborne-atopy without
wheeze led to airborne-atopy with wheeze. Unlike figure 5.5, there is no edge going back
the other way.
and include different information. The DBNs cannot describe relationships within a
given year-of-life, although they may detect those which occur across sequential years,
whereas the χ-squared test can. On the other hand, the χ-squared test cannot consider
more than one pair of years at a time, while ARTIVA samples over an optimal range of
years and can so avoid confounding effects associated with simultaneous changes over
time between the two variables.
Tables 5.1 to 5.7 present the p-values from the χ-squared test. Where a link was
predicted by ARTIVA it is presented in boldface, along with the p-value that was
actually the smallest. We consistently found that the smallest p-value in each line of
these tables corresponded to either the predicted edge or to values within the same year.
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As such, the χ-squared test was always consistent with the inferred DBNs.
Figure 5.7: Airborne-atopy led to severe-LRI. With intermediate posteriors,
it also led against URI while wheeze led to severe-LRI :
5.3 Atopy, infection, and persistence of wheeze
It is a long-established result that early childhood infections, especially febrile or wheezy
infections, and viral infections, are associated with later childhood asthma. The same
is true of childhood atopy, with 80-90% of asthmatics also suffering atopic (IgE -based)
allergy [11,19]. Figures 5.1 to 5.4 show atopy acting on the number of infections, rather
than the other way around. There is an increase in LRI and, in the last of these
figures (figure 5.4), a decrease in URI. The biologically plausible interpretation is that
aeroatopic-wheeze makes it easier for infectious agents to get into the lungs, so that
some infections which would have been recorded as URI s instead became LRI s.
It has long been known that wheeze commonly occurs in infants in the first two
or three years of life only to resolve by about five years of age. Indeed, it is the
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Figure 5.8: Airborne-atopy led to wheezy-LRI. With low posterior it also led
against URI : There is a low-posterior link from wheeze to wheezy-LRI, which is not
surprising.
persistence of wheeze into the fifth year-of-life that we have taken as our proxy for
childhood asthma. Figure 5.5 indicates that the co-occurrence of atopy with wheeze
increases the probability of the wheeze persisting into the fifth year-of-life. The effect
is even stronger when atopy is restricted to airborne-atopy (figure 5.6), and vanishes
when restricted to atopy to non-airborne allergens, or nonairborne-atopy (not shown).
It would seem that the co-occurence of airborne-atopy is almost sufficient, but not
necessary, to ensure that wheeze persists. Figures 5.5, 5.6 indicate that airborne-atopy
could lead to fifth-year -wheeze on its own, but the effect is weaker, with lower probability
(see legend in appendix G), and apparently via atopic-wheeze in a later year. Conversely,
wheeze-without-airborne-atopy can persist to the fifth year-of-life but is more likely to
be transient. The χ-squared test yields results consistent with this, as shown in tables
5.1 and 5.2.
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Figure 5.9: Airborne-atopy with wheeze led against URI. Airborne-atopy and
wheeze on their own led to severe-LRI :
5.4 Did LRI lead to atopy and wheeze?
Since respiratory infections, especially lower respiratory infections, are associated with
asthma risk, we put URI, LRI, atopy or airborne-atopy, and wheeze in the same network.
As already mentioned, airborne-atopy seemed to lead against URI, as shown in figure
5.4. However, the posteriors of these effects are low-to-intermediate. As discussed in
section 5.2.5, this might indicate that only a subset of infections are involved. Easy
distinctions to make between infections include the copresence of wheeze and fever, and
whether or not they are viral.
78 Chapter 5: Inferred dynamic Bayesian networks
aeroatopic-wheeze
URI minus severe-LRI previous year same year following year
URI, wheezy-LRI - yr 1 NA .045 .183
URI, wheezy-LRI - yr 2 .0103 .047 .344
URI, wheezy-LRI - yr 3 .635 6.69× 10−3 .011
URI, wheezy-LRI - yr 4 2.23× 10−6 3.98× 10−6 1.75× 10−4
URI, wheezy-LRI - yr 5 2.10× 10−4 .022 NA
Table 5.3: χ-squared test p-values of the effect on the difference between the number of
URI s and wheezy-LRI s from atopic-wheeze-status in the previous, same and following
year. There is fair but incomplete agreement with the edges inferred in figure 5.11.
Some effects are found here to occur on a timescale shorter than one year.
atopic-wheeze
viral-URI minus severe-viral-LRI previous year same year following year
First year-of-life NA .172 .642
Second year-of-life 1.98× 10−3 5.83× 10−3 .387
Third year-of-life .414 1.86× 10−3 .177
Table 5.4: χ-squared test p-values of the effect on the difference between the number of
viral-URI s and severe-viral-LRI s from atopic-wheeze-status in the previous, same and
following year. There is fair but incomplete agreement with the edges inferred in figure
5.14. Some effects are found here to occur on a timescale shorter than one year.
5.4.1 Atopy and wheeze led to LRI
To clarify the role of LRI we first decomposed it into severe- and mild- LRI. The
resulting network (figure 5.7) finds the same positive effect of airborne-atopy on URI
but also that it lead to severe- but not mild- LRI. Figure 5.7 also indicates that wheeze
contributed to severe-LRI in a subset of cases. The same network inferred after mean-
imputing missing data, figure H.1, was essentially the same except that the negative
effect on URI was missing and the edge from wheeze to severe-LRI was darker.
Dividing severe-LRI further into its wheezy and febrile subsets, shown in figure 5.8,
we found the positive effect of airborne-atopy is restricted to wheezy-LRI, with a dark
edge indicating near-unit posterior. It follows that airborne-atopy led to wheezy-LRI.
The network inferred by mean-imputing missing data is again much the same, but
with a darker edge from wheeze to wheezy-LRI, and the dashed edge to URI vanishes
altogether.
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Figure 5.10: Airborne-atopy with wheeze led against URI and to wheezy-
LRI : Airborne-atopy and wheeze also led to wheezy-LRI in isolation, but with weaker
coefficients and lower posteriors, with the former being stronger and more probable than
the later.
5.4.2 Atopy and wheeze led against URI
To better understand the apparent effect on URI we sought a relevant edge with near-
unity posterior. To see if only certain subsets of airborne-atopy cases led against URI,
we replaced airborne-atopy and wheeze in figure 5.7 and instead considered cases of
both (airborne-atopy with wheeze), or just one (airborne-atopy only or wheeze only),
as shown in figure 5.9. This immediately yielded a high posterior edge leading against
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Figure 5.11: Airborne-atopy with wheeze, and to a lesser extent without
wheeze, led to URI becoming wheezy-LRI : We verified this result with the χ-
squared test. The p-values are presented in table 5.3.
URI, indicating that aeroatopic-wheeze led against URI. Repeating our above division of
severe-LRI into febrile- and wheezy- LRI, shown in figure 5.10, found that the positive
effects of airborne-atopy and wheeze were limited to wheezy-LRI with an even (slightly)
higher posterior while the negative effect on URI by aeroatopic-wheeze was essentially
unchanged. (The mean-imputed networks, figures 5.9 and 5.10 were essentially the
same. Consistent with earlier mean-imputed networks, the differences were darker edges
leading to severe-LRI and wheezy-LRI, respectively, and fainter edges leading against
URI.) We are unable to comment on whether this is due to some interaction between
airborne-atopy and wheeze, or if the presence of wheeze is an indicator of the severity
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Figure 5.12: Airborne-atopy led against viral-URI. In the first year-of-life,
with low-to-intermediate posterior, it led to viral-LRI : Airborne-atopy also
lead to wheeze and all variables are ongoing.
of airborne-atopy .
5.4.3 Aeroatopic-wheeze turned URI into LRI
One would not expect airborne-atopy or wheeze to protect against infection, and the
most biologically plausible interpretation of aeroatopic-wheeze leading against URI is
that it makes it easier for infectious agents to enter the lungs, effectively allowing what
would have been URI s to become LRI s. We have just seen that it is wheezy-LRI s in
particular that are increased, so the effect of aeroatopic-wheeze on URI s would be to
turn them into wheezy-LRI s.
A DBN to better test this statement would seek not the effect of aeroatopic-wheeze
on URI and wheezy-LRI individually, but on the balance between them. One of the
former becoming one of the latter is mathematically equivalent to taking a weight from
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Figure 5.13: Airborne-atopy led against viral-URI with intermediate poste-
rior:
one side of a balance and placing it on the other. The balance then moves in response
to the change in the difference between the weight on either side, although the total
weight on the balance scale is obviously the same. Analogously, it is the change in
the difference between URI and wheezy-LRI while the sum total of these two infection
types remains constant that corresponds to our proposed effect of aeroatopic-wheeze on
URI. The corresponding network from imputed data was almost identical except that
the negative edge leading to the difference between URI and wheezy-LRI is absent (see
figure H.5).
Applying the χ-squared test to figure 5.11 further supported the result that aeroatopic-
wheeze led to wheezy-LRI in the place of URI . The relevant p-values are shown in ta-
bles 5.3. The apparent effect is most significant within each year-of-life, indicating a
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Figure 5.14: Both airborne-atopy and wheeze led to an increase in severe-
viral-LRI with a simultaneous decrease in viral-URI, the latter with only
intermediate posterior: A natural interpretation is airborne-atopy and wheeze allow
what would have otherwise been a viral-URI to enter the lungs and become a severe-
viral-LRI. We tested this link with the χ-squared test. The corresponding p-values are
in table 5.4 and support the effect of airborne-atopy in this figure.
timescale significantly shorter than the yearly resolution of CAS data. In the first two
years-of-life the p-values indicate an effect of earlier aeroatopic-wheeze on subsequent
URI vs LRI, with no evidence of flow in the opposite direction. In later years the
picture is less clear, although the most significant signal occurs within the given year.
By contrast, variation of the total number number of infections as a function of
aeroatopic-wheeze never scored p-values less than 0.7.
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Figure 5.15: Airborne-atopy led to an increase number of wheezy-viral-LRI s at
the expense of viral-URI s. With intermediate posterior, both airborne-atopy
and wheeze also led to an exchange of viral-URI s for febrile-viral-LRI s:
5.4.4 The importance of viral status
Restricting the infections in figure 5.4 to be viral yielded the network in figure 5.12. The
edges leading to viral-LRI from airborne-atopy are very similar but those from wheeze
are clearly darker than their counterparts in figure 5.4. Edges leading against viral-URI
from airborne-atopy are also darker than in figure 5.4.
Given the results of the previous subsection, we divided viral-LRI into severe- and
mild- cases, which is shown in figure 5.13. The negative effect against viral-URI remains
but the edges leading to severe-viral-LRI and mild-viral-LRI are faint and non-existent,
respectively. There is further degradation when severe-viral-LRI is further separated
into wheezy and febrile infections (not shown). This is surprising, given our discussion
of figures 5.4 and 5.13.
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Figure 5.16: Airborne-atopy led to viral-LRI s and not the other way around:
Another effect which does not seem to be conserved by the restriction to viral in-
fections is the effect of combining wheeze and airborne-atopy , like in figures 5.9 and
5.10. Indeed, the network obtained by making this variable change to figure I.1 found
the corresponding link to wheezy-viral-LRI with a much lower posterior while in those
based on the figures 5.12 and 5.13 the edge leading against viral-URI doesn’t appear
at all (not shown). We recall that ARTIVA samples across timesteps and infers phases,
and in the first year-of-life there were only eight cases of aeroatopic-wheeze(see table
C.2), with the condition more prevalent in the excluded later years. This makes it likely
that there is insufficient statistical power to infer these edges for viral-LRI s, for which
there are only three years of data. If that is the case then we might still be able to
replicate the effect shown in figure 5.11 in a network restricted to viral infections.
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Figure 5.17: Airborne-atopy led to viral-LRI, and not the other way around:
Viral-LRI s not accompanied by airborne-atopy were highly unlikely to lead to other
viral-LRI s.
We therefore inferred networks to test if airborne-atopy and wheeze led to viral
infections being wheezy-LRI s rather than URI s, shown in figures 5.14 and 5.15. We
found a corresponding negative link from airborne-atopy to the difference between viral-
URI and severe-viral-LRI in the former of these networks. In the latter we found a
similar edge for wheezy-viral-LRI and another, though only of intermediate posterior,
for febrile-viral-LRI.
The corresponding networks for non-viral infections (not shown), found no connec-
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Figure 5.18: Airborne-atopy led to severe-LRI and not the other way around:
Nonairborne-atopy typically resolved the following year.
tions with wheeze or airborne-atopy, but given the low numbers of non-viral infections,
we refrain from drawing any conclusions.
5.5 Viral-LRI s and continuance of atopy
5.5.1 Viral-LRIs accompanied by airborne-atopy did not lead to airborne-
atopy
Having seen that airborne-atopy led to viral-LRI and not the other way around, we
considered whether there might be a positive feedback loop, in which infection accom-
panied by airborne-atopy led to aggravated airborne-atopy. We focussed on airborne-
atopy since nonairborne-atopy was found to not contribute to later wheeze as per our
discussion of figures 5.1 through 5.4. The reader is reminded again of the legend in
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Figure 5.19: There is no evidence that severe-LRI led to airborne-atopy if it
wasn’t already present, even in the presence of nonairborne-atopy :
appendix G.
In figures 5.16 and 5.17 we considered whether the viral-LRI s were accompanied by
airborne-atopy . If severe-, febrile- or wheezy- viral-LRI contributed to the persistence
of airborne-atopy then the signal would be stronger from those infections for which
airborne-atopy was already present. After all, airborne-atopy must be present if it
is to persist! What these figures indicate however is that airborne-atopy still led to
viral-LRI and not the other way around.
Figure 5.18 also indicates that airborne-atopy, with or without wheeze, led to severe-
LRI and not the other way around.
There has been discussion in the literature [6, 16] about whether viral infection
can lead to atopic responses in the lungs. All DBNs shown so far indicate that any
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Figure 5.20: The number of aeroatopies, and not infections, drives the number
of aeroatopies: Multiple aeroatopies led to wheezy-LRI, but there was negligible effect
on other infection types.
causal influence is in the opposite direction, but we considered whether nonairborne-
atopy might be more likely to lead to airborne-atopy given the co-occurence of severe-
LRI. Figure 5.19 clearly indicates that the link is tenuous at best, with the posterior
probability being lower when severe-LRI is present.
We therefore continue to find that it is airborne-atopy that led to LRI and not
the other way around, although the figure 5.18 seems to indicate that the copresence of
severe-LRI with airborne-atopy led to ongoing airborne-atopy . We cannot yet comment
on whether this is causal or due to the atopic being infection-prone.
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febrile-LRI
aeroatopy-number previous year same year following year
First year-of-life NA < 2.2× 10−16 2.22× 10−7
Second year-of-life 1.62× 10−12 3.65× 10−14 1.82× 10−4
Third year-of-life 1.88× 10−12 1.19× 10−13 1.61× 10−6
Fourth year-of-life 2.12× 10−15 2.51× 10−12 7.2× 10−5
Fifth year-of-life 2.51× 10−3 6.55× 10−3 NA
Table 5.5: χ-squared test p-values of the interaction between aeroatopy-number and the
number of febrile-LRI in the same and adjacent years-of-life, where the febrile-LRI are
accompanied by airborne-atopy. Figure 5.20 does not show the relationship suggested
here, but figure 5.21 reflects it quite closely, once the restriction to purely-febrile-LRI
is made and the copresence of of airborne-atopy is required.
5.5.2 Severe-LRIs and the number of atopic triggers
In subsection 3.2.2 we found atopy-number in the first year-of-life to be an excellent
predictor (AUC = .81) of atopic-wheeze in the fifth year-of-life. It appears to have little
interaction between the number of infections, with only a mild effect on wheezy-LRI seen
in figure 5.20. The situation changed if infections were divided according to whether
they were accompanied by airborne-atopy, (figure 5.21). In common with subsequent
figures, figure 5.21 finds a link from aeroatopy-number to febrile- and wheezy- LRI in
the first year-of-life but the edges run from febrile-LRI to aeroatopy-number from the
second year-of-life onwards. The face-value interpretation of this observation is that
febrile-LRI led to an increasing, or prevented a decreasing, number of atopic triggers
in those that were aeroatopic already. However it is also plausible that a propensity for
increasing atopy-number coincides with susceptibility to febrile-LRI, so we cannot state
on this evidence that febrile-LRI s aggravate atopy.
5.5.3 Effect of infection on aeroatopy-number
Figure 5.22 indicates that in the first year-of-life it is aeroatopy-number that led to viral
infection and not the other way around. It further indicates that the only infections to
link with aeroatopy-number, or even other infections for that matter, were accompanied
by airborne-atopy.
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Figure 5.21: All infections are assumed to be accompanied by airborne-
atopy. Purely-febrile-LRI led to aeroatopy-number. Aeroatopy-number led
to wheezy-LRI, especially in the first year-of-life, and led to febrile-LRI in
the first year-of-life:
5.5.4 Causality runs from aeroatopy-number to severe-viral-LRI in
the first year-of-life
Figure 5.23 indicates that mild-viral-LRI accompanied by airborne-atopy led against
lower aeroatopy-number.
It is biologically implausible that mild-viral-LRI would actively lower aeroatopy-
number, and combining this with the failure of severe-viral-LRI to affect aeroatopy-
number in figures 5.22, we found that that the infections’ lack of severity indicates
that the aeroatopy-number is not increasing, i.e. a propensity to increasing aeroatopy-
number is associated with severe-viral-LRI among those with airborne-atopy. Indeed,
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wheezy-LRI
aeroatopy-number previous year same year following year
First year-of-life NA 1.70× 10−14 3.18× 10−9
Second year-of-life 8.24× 10−14 1.77× 10−12 4.76× 10−16
Third year-of-life 6.68× 10−9 < 2.2× 10−16 1.61× 10−6
Fourth year-of-life 3.77× 10−9 4.55× 10−13 1.62× 10−5
Fifth year-of-life 5.22× 10−9 1.33× 10−7 NA
Table 5.6: χ-squared test p-values of the interaction between aeroatopy-number and
the number of wheezy-LRI in the same and adjacent years-of-life, where the wheezy-
LRI are accompanied by airborne-atopy. For the first four years-of-life there is strong
evidence of an effect, but without a clear chronological direction since it takes place on
a timescale much shorter than one year. There is agreement with the network in figure
5.20 that the chronological arrow goes from aeroatopy-number to wheezy-LRI in the
first year-of-life, and the opposite direction in the fifth, but they disagree as to when
that reversal takes place. However both approaches, each in their own way, indicate a
corresponding uncertainty in their edges.
mild-viral-LRI
aeroatopy-number previous year same year following year
First year-of-life NA 2.166× 10−6 2.292× 10−4
Second year-of-life .235 < 2.2× 10−16 .1785
Third year-of-life 1.855× 10−7 3.742× 10−6 NA
Table 5.7: χ-squared test p-values of the interaction between aeroatopy-number and
the number of mild-viral-LRI in the previous, same and following year, where the mild-
viral-LRI are accompanied by airborne-atopy. While there is no support for the specific
edge connecting first-year mild-viral-LRI to second-year aeroatopy-number, there is
strong support for an effect acting within each year-of-life, especially second year. This
supports our interpretation of figure 5.23 that susceptibility to severe-viral-LRI accom-
panying airborne-atopy indicates a predisposition for increasing aeroatopy-number.
we have argued in section 5.4.4 that airborne-atopy led to severe-viral-LRI, especially
in the presence of wheeze. This is consistent with the aforementioned analysis by Wen-
nergren and Kristjánsson [60] finding that severe RSV infection followed by wheeze
indicated an underlying mutual cause. This result is important so we verified it with
the χ-squared test, shown in table 5.7. This demonstrated a functional relationship
between aeroatopy-number and mild-viral-LRI in the presence of airborne-atopy, with
a very significant signal in the second year-of-life. As an additional check, we tested for
a corresponding relationship with mild-viral-LRI in the absence of airborne-atopy. The
required negative result is presented in table I.1.
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Figure 5.22: Nothing in the first year-of-life led to aeroatopy-number except
itself, but aeroatopy-number in the first two years-of-life led to wheezy-
viral-LRI (with airborne-atopy). Febrile-viral-LRI with airborne-atopy in
the second year-of-life led to aeroatopy-number. Infections not accompanied
by airborne-atopy did not lead to other infections, and only wheezy-viral-LRI
is ongoing:
To test the robustness of this result we split severe-viral-LRI into its febrile and
wheezy subtypes, as shown in figure 5.24. Not only did first-year aeroatopy-number lead
to febrile- and wheezy- viral-LRI, but first-year mild-viral-LRI led against aeroatopy-
number, just as it did in figure 5.23. This supports our earlier finding that it is airborne-
atopy that led to severe-LRI and not the other way around.
These figures also indicate that severe-LRI, and especially febrile-LRI, led to higher
aeroatopy-number in those that were already aeroatopic from the second year-of-life
onwards. Given that our earlier DBNs found that airborne-atopy led to wheezy-LRI
but not febrile-LRI, regardless of viral -status, this would seem to be of significance.
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Figure 5.23: Mild-viral-LRI led against aeroatopy-number, indicating that
aeroatopy-number causes severe-viral-LRI, and not the other way around:
Whether febrile-LRI was the actual causal agent, or was merely associated with it,
cannot be determined here. The root causes of asthma are believed to occur within
the first two years-of-life [5,173], but protection against febrile-LRI or febrile-viral-LRI
may be an option for arresting pathogenesis.
Table I.1 checks the dependence on airborne-atopy of infections without airborne-
atopy, and finds a greatly reduced significance as required by figures 5.23 and 5.24.
5.6 IgE dynamics and future wheeze-status
How IgE titres developed over time differed between those who went on to exhibit wheeze
in the fifth year-of-life and those who did not. Our discussion of this will heavily involve
the occurence of IgE titres blowing out to enormous values among atopics. Like most of
the variables already studied, our networks show that the value of a variable in a given
time-step is dependent on its value in the previous time step. The important observable
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Figure 5.24: First-year mild-viral-LRI, in the presence of airborne-atopy, led
against aeroatopy-number. This apparent protection indicates that it is
airborne-atopy that led to severe-viral-LRI, with failure to be severe indi-
cating that aeroatopy-number was unlikely to increase. Aeroatopy-number
in the first year-of-life led to both febrile- and wheezy- viral-LRI (with
airborne-atopy):
difference is that for IgE -related variables the dependence is often much stronger, so that
instead of merely maintaining a condition the variables’ value is growing exponentially.
We sometimes say that the variable in question is self-stimulating.
Consider the networks shown in figures 5.25 and 5.26. In the network corresponding
to fifth-year wheeze, there is a marked tendency for exponential growth of IgE. This is
much less marked for the non-wheeze network, figure 5.25, where IgE increase, especially
for house-dust-mite IgE, is much more dependent on the IgE of other allergens.
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Figure 5.25: House-dust-mite IgE showed exponential growth in the first year-
of-life. Couch-, mould- and peanut- IgE led to house-dust-mite IgE from
the first year-of-life, but not the first six months-of-life. Rye- and cat- IgE
led against house-dust-mite IgE in the same period: Network generated from
participants who did not exhibit wheeze in their fifth year-of-life. Additional, later
cross-linking among other IgE s.
Figures 5.27 and 5.28 show the corresponding networks with the logarithm of those
variables. We see in these figures that in those who went on to exhibit fifth-year wheeze
it was (log of) house-dust-mite IgE that was leading to other IgE s. It should not
be a surprise that the IgE dynamics leading to fifth-year wheeze were manifest at a
logarithmic scale. The IgE distributions of those who developed wheeze in the fifth
year-of-life were very heavily skewed, even in comparison to those who did not.
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Figure 5.26: House-dust-mite IgE lead against itself in the first six months-
of-life, with intermediate posterior, and lead against peanut-IgE also in that
and the next timestep. Peanut-IgE in the first six months-of-life lead to
house-dust-mite IgE. All other cross-linking is negative, including rye and
couch:
Network generated from participants who exhibit wheeze in their fifth year-of-life.
5.7 Relations among atopic allergens
We make some observations about the dynamics of IgE titres.
Figure 5.26 indicates various relationships among the different IgE s. The first is a
link from peanut-IgE in the first six months to house-dust-mite IgE in the first year-of-
life. This explains how wheeze accompanied by peanut atopy in the fifth year-of-life is
so well predicted by (log of) house-dust-mite IgE in the second year-of-life.
Another notable feature is the self-stimulated growth of mould -IgE, which begins
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Figure 5.27: Network among participants who did not wheeze in the fifth year-
of-life. There is only minimal cross-linking between different IgE allergens
at the logarithmic scale:
in the third year-of-life. The reader may recall from section 3.4 that mould -specific
atopic-wheeze was difficult to predict from second-year IgE but was well-predicted by
mould -IgE in the third year-of-life.
5.7.1 Multiple atopies and IgE titres
Given these inter-allergen dependencies, it seemed prudent to consider the interaction
of atopy-number with the IgE of various allergens. Figure 5.29 indicates that atopy-
number led to (log of) house-dust-mite IgE in the first year-of-life, but otherwise it
was (log of) peanut-IgE and mostly house-dust-mite IgE leading to atopy-number. In
conjunction with the last four figures, especially figures 5.25 and 5.28, we see a pattern
of atopy development, beginning with elevated peanut-IgE leading to elevated house-
dust-mite IgE and then on to one or more other elevated IgE s. The mutual interaction
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Figure 5.28: Network from participants who exhibited wheeze in their fifth
year-of-life. This network differs from figures to edges leading from (log of)
house-dust-mite IgE : There is also some later-year positive cross-linking between
(log of) rye-IgE and (log of) couch-IgE, unsurprising since they are both grasses, and
negative faint cross-linking in the first two years-of-life.
between atopy-number and (log of) house-dust-mite IgE is consistent with the multi-
allergen endotype discussed in section 3.4. The significance of the other cross-linking
among the different allergens is not clear.
Replacing atopy-number with aeroatopy-number (see appendix I.3) gives a similar
graph, though with more faint edges among allergens and no link from first-year atopy-
number to second year (log of) infant-phadiatop-IgE, and we prefer the “cleaner” graph
of atopy-number .
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Figure 5.29: (Log of) peanut-IgE and house-dust-mite IgE were the drivers
of increasing atopy-number. Atopy-number in the first year-of-life lead to
(log of) house-dust-mite IgE :
5.8 Altered interleukin dynamics
We did not find any obvious links between interleukin and wheeze. There was too much
missing data to find a DBN from those who did develop fifth-year wheeze, and we were
further inhibited by lack of data from the third and fourth years-of-life.
We found interleukin networks for ovalbumin and for tetanus. However, clear dif-
ferences were found among networks inferred from all participants and those inferred
from those who went to exhibit, and not exhibit, wheeze in the fifth year-of-life.
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Figure 5.30: Among those who did not exhibit fifth-year wheeze, ovalbumin IL-
5 in the second year-of-life led to itself and ovalbumin IL-13 and IFN-γ, the
latter with only intermediate posterior. The dynamics are very different
from those of the unconditional network shown in figure 5.31:
Ovalbumin IL-5 in the second year-of-life led to ovalbumin IFN-γ, ovalbumin IL-13,
and itself, in the fifth year-of-life, the first of these with only intermediate posterior,
in those who did not have wheeze in the fifth year-of-life. The corresponding DBN
generated using all complete records finds no edges among any of the ovalbumin IL
(not shown), but an interesting DBN was found by taking the log() of the interleukin
values. The DBN in figure 5.31 indicates that ovalbumin IFN-γ, IL-10 and IL-13 led to
house-dust-mite IgE .
The corresponding DBNs for tetanus, shown in figures 5.32 and 5.33, also display
evidence of changes in interleukin regulation. There is no interleukin which appears to
be of greater importance than any other. An association was published [169] between
IL-γ and severe asthma in both mice and humans. We do not see it here, but this is
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Figure 5.31: (Log of) ovalbumin IL-13 and IFN-γ in the second year-of-life led
to fifth-year house-dust-mite IgE, while (log of) ovalbumin IL-10 led against
it. (Log of) ovalbumin IL-5 is ongoing from the first year-of-life:
not surprising given its limited endotype (less than 10% of all asthma [3]) and the great
deal of missing data among the interleukin variables.
The DBNs of interleukin were often empty and the few interesting networks we
did find did not point to any clear culprit. What they did indicate is an apparent
disregulation among interleukins, indicating a deeper underlying cause. IL-5 seemed to
be involved in the differences between networks for both ovalbumin and tetanus. The
significance of this is not known.
5.9 Outcomes
Much of this chapter was concerned with the interplay among infection, wheeze and
atopy. Our networks do not support recent suggestions that viral-LRI leads to airborne-
atopy or atopic-wheeze. In fact, there was a consistent pattern of infection being con-
sequential rather than causal of atopy and wheeze. The possible exception is that
febrile-viral-LRI from the second year-of-life onwards might increase the atopy-number
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Figure 5.32: Tetanus IL-10 in the first six months-of-life led to tetanus IFN-
γ, while in the third year-of-life it led to tetanus IL-5 in the fifth year-of-
life. All edges from tetanus IL-10 have intermediate posterior. House-dust-
mite IgE in the third year-of-life led to tetanus IL-5 and to tetanus IL-13
in the fifth year-of-life, the latter with intermediate posterior. In common
with figure 5.33, there was also interaction between tetanus IL-5, 13, which
in the first six months-of-life, lead to tetanus IFN-γ:
in those who are already atopic, but this might also be due to an atopy-inclined immune
system being more likely to generate a fever.
As discussed in section 5.5.4, our analysis cannot address questions concerning re-
modelling, specific virii, or infection in the early weeks-of-life. Within these caveäts,
our model inferred the following :
1. Wheeze led to more wheezy-LRI (figures 5.1 to 5.10) and viral-LRI (figure 5.12).
2. Airborne-atopic-wheeze led to wheezy-LRI which would otherwise have been URI
(figure 5.11).
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Figure 5.33: Among those who did not exhibit wheeze in the fifth year-of-life,
interaction between tetanus IL-5, 13, which in the first six months-of-life,
led to tetanus IFN-γ:
3. Airborne-atopy led to fewer viral-URI and more severe-viral-LRI. Of most impor-
tance were the wheezy-viral-LRI (figures 5.14 and 5.15).
4. Nonatopic-wheeze frequently resolves while atopic-wheeze does not unless the un-
derlying atopy resolves (figures 5.5 and 5.6). We suspect that other forms of
inflammation also prevent the resolution of wheeze, but that this dataset is too
biased towards atopy to reach reliable conclusions about this.
5. Increasing aeroatopy-number in the first year-of-life led to severe-viral-LRI, and
not the other way around. Biologically this means that a tendency for increasing
numbers of atopic sensitivities also led to more severe-viral-LRI.
6. Febrile-viral-LRI did not cause airborne-atopy but, from the second year-of-life
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onwards, led to higher aeroatopy-number if airborne-atopy was already present
(figures 5.22 and 5.24). We cannot determine if this relationship is indicative or
causal, so it is plausible that protecting against febrile-viral-LRI from the second
year-of-life onwards might lead to a drop in atopy-number. This issue requires a
specific intervention study.
7. We found no connection between nonviral-LRI and wheeze, atopy or airborne-
atopy (generally not shown but see figure 5.22). We cannot rule out a lack of
statistical power.
8. IgE dynamics are fundamentally different between those who later exhibit wheeze
in the fifth year-of-life and those who do not. The former have much less cross-
linking between different IgE s, apart from house-dust-mite IgE being dependent
on earlier values of other IgE s. Conversely, the latter have house-dust-mite IgE
driving the IgE s of other allergens, especially cat, couch and rye, although peanut-
IgE in the first six months-of-life led strongly to house-dust-mite IgE in the first
year-of-life (figures 5.25 to 5.28).
9. Atopy-number initially led to and was later led to by house-dust-mite IgE . The
only other IgE to visibly interaction with atopy-number was peanut, which led to
it in the first six months-of-life (figure 5.29).
10. Interleukin dynamics are fundamentally different between those who later exhibit
wheeze in the fifth year-of-life and those who do not. The differences include




6.1 Identification of individual endotypes by classification
Asthma is a complex disorder, comprising multiple endotypes with differing causes,
triggers and aetiologies. Contributing factors are generally predictive of only their own
particular endotype, adding further to the difficulty of predicting wheeze in the fifth
year-of-life. This is especially true when the endotype in question is such a small subset
that the contribution to the general condition becomes swamped by noise.
The flipside is that we could use this selectivity to identify useful endotypes. It is
a trivial matter to specify subsets of a general case, but only some are worthwhile. We
were able to identify meaningful endotypes because their predictors did not just score
AUCs predicting them that were higher than they did predicting the general case, but
predictably higher, within a narrow margin for error. The clearest example of this was
the known [20] second-year predictor, (log of) house-dust-mite IgE . Despite being the
best predictor of fifth-year wheeze in the CAS study (atopy-number was constructed
from CAS variables rather than being in CAS itself), its predictive ability was exclusive
to the very specific multi-allergen endotype of atopic-wheeze requiring atopic sensitivity
to at least one of cat, peanut, couch or rye.
6.2 Associations between the NP microbiome and asthmatic out-
comes
Our study of the NP microbiome in the context of fifth-year wheeze and atopy, pre-
sented in chapter 4, considered two general cases. The first was samples taken from
individuals during the course of a respiratory infection during the first 90 days-of-life.
Dual qq-plots, i.e. one qq-plot for cases and one for controls on the same pair of axes,
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associated higher levels of Haemophilus with nonatopic-wheeze in the fifth year-of-life,
while Staphylococcus was associated with increased risk for atopic-wheeze against which
Moraxella was found to be protective. The axes were the relative abundances of one
of the genera, Alloiococcus, Streptococcus, Staphylococcus, Haemophilus, Moraxella and
Corynebacterium, that typically constituted the NP microbiome.
The second general case was samples taken during the first seven weeks-of-life (< 50
days) when the individual did not have a respiratory infection. The dual qq-plots
found only one signal, that for Streptococcus and fifth-year wheeze. This is not the first
evidence for such an association [7], although the predictive signal from Streptococcus
became noteworthy only when specific atopic-allergens were considered. Of particular
interest were the allergens associated with the multi-allergen endotype presented in
section 3.4. All but rye were very well predicted with AUCs in the 80% range. Our
exclusivity index from chapter 3 did not find it to be exclusive to any given endotype,
but given the small number of cases this may well be due to a lack of statistical power.
In both general cases the genera of interest generally indicated their signals regard-
less of which other genus they were plotted with, with very few exceptions. We were
prepared for more complication than this, imagining interaction between genera with
regards to pathological conditions. As it was, the evidence indicated that specific genera
had certain associated risks.
6.3 Results from ARTIVA-derived DBNs
High-powered cohort studies like CAS which include diverse data types typically in-
clude a range of different, non-Gaussian probability distributions. Bayesian tools typi-
cally assume Gaussian distributions, with results often better than might be intuitively
expected [123–128], although it has still been shown to be a significant limitation on
performance in some instances [115,117,132].
The Gaussian prior makes this assumption about the model coefficients, rather than
the data itself. For continuous data this is a gentler assumption, allowing the Gaussian
process prior to render the calculation tractable [8], without inherent conflict with the
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data. However for discrete and binary data the implicit assumption of continuous data
is fundamentally problematic. We addressed the issue with the long-known procedure
of Albert and Chib [9], as discussed in subsection 5.2.2. Future extensions might in-
clude implementing logistic regression for binary variables instead of defaulting to linear
regression.
Additionally, transcending the Gaussian distribution assumption also allowed us
to study the interactions between factors without taking subsets of our already limited
sample size. We could, for example, consider infections with and without atopy, without
having to consider the atopic and non-atopic samples separately, by multiplying the
number of infections by zero or one, according to the atopic status of the participant
in question. This sometimes led to very limited numbers of cases for some binary
conditions, such as aeroatopic-wheeze in the first year-of-life. We present the number
of cases for important binary conditions in appendix C.
In addition to the edge weights (dependency strengths), ARTIVA’s output also in-
cludes the edges’ posterior probabilities. They correspond to the posterior probability
that the edge is present, but we have found it helpful to interpret it as the (approx-
imate) fraction of samples to which the relationship applies. Doing so allowed us, in
combination with biological understanding, to identify relevant subsets and conditions
e.g. the intermediate posterior associated with atopy led us to consider airborne atopies
separately. In this way we were led to useful conditions and subsets by the data, in-
stead of needing to consider every possible combination. Recall our requirement that
networks only contain edges of near-unity posterior. Instead of simply eliminating edges
with posteriors below a given cutoff, we willing incurred the liability of finding networks
whose edge posteriors were all sufficiently high. This led us to unexpected consequences
of this model for the effect of atopy and wheeze on infections’ ability to get into the
lungs. Not only was this the most natural way to understand the negative effect on
URI, but it also generated the most likely edges on the best graphs.
While other feasible approaches may well exist, a guided approach such as ours was
certainly necessary. The highly heterogenous nature of CAS variables, combined with
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the correlations expected among variables selected for a common association, and indeed
sometimes with overlapping definitions, ruled out the effectiveness of straightforward
“all-at-once” methods. However even our use of intermediate posteriors required a choice
of starting network, and in this we were led by some of the biological questions currently
discussed in the asthma field [6, 16, 20], focussing on the interplay between atopy and
infection.
Both of these guides required biological insight on the part of the researcher. We
make no apology for this, it being appropriate for reasons other than necessity for,
despite our data-centric approach, this was at heart a biological problem.
Our networks concerning atopy and infection have consistently indicated, at least
in this model, that it is the former which led to the latter, and not the other way
around. Even the one possible exception, febrile-viral-LRI leading to higher atopy-
number, required the copresence of airborne-atopy as indicated in figure 5.24. Whether
this edge indicates a genuine effect or merely an indicative relationship, the infection
was not the seminal factor. Enquiries into the development of IgE -titres revealed highly
disparate networks between those who went on to develop fifth-year wheeze and those
who did not. Nonetheless, house-dust-mite IgE was shown to have played a pivotal
role, being the child nodes in the non-wheeze networks and the parent nodes in wheezy
ones. Figure 5.29 further indicates that (log of) house-dust-mite IgE was stimulated by
atopy-number but also led back to it.
Important findings, especially those regarding infection, from this ARTIVA-based
model were supported by the χ-squared test, but it is nonetheless prudent to indicate
the limitations of this model. Its inherent linearity and year-by-year time-resolution
leave it prone to missing relationships that are highly non-linear or whose time-scale is
much shorter than one year. This latter point is especially important for data in early
infancy, where significant variables were found within the first few weeks- and months-
of-life. Addressing the former point might open the door to a new form of overfitting,
but that might be overcome with an adaption of Albert and Chib’s augmentation [9] or
with information theory-based methods [174–177].
Chapter 7
Conclusion
The complexity of asthma pathogenesis is undeniable. A large part of this is the sub-
stantial number of endotypes whose variations cover predictors, severity, age-of-onset,
atopy-status, medication response, and triggers. Nor are all triggers atopic, with cold
and exercise triggering attacks in some cases [15].
We have demonstrated, through our novel exclusivity index, that some biologically
important variables were predictive of specific endotypes only, while other important
variables, notably severe- and febrile- LRI, were not endotype specific but predictive of
wheeze in general. This raises questions concerning the causal status of infection. If,
as some researchers believe [178,179], viral infections play a causal role then either the
outcome is very dependent on the specific virus or the pathogenic effects are dependent
on other variables, such as the theorised interaction between viral-LRI and atopy [16].
However, our finding in subsection 5.5.1 was that viral-LRI were not causal of
wheeze or atopy, but caused by them, which sits well with the non-exclusive nature
of infection as a predictor. The only active role indicated by our model was for febrile-
viral-LRI, as a preserver of airborne-atopy from the second year-of-life onwards. The
simplest interpretation is that atopy-prone immune systems are inclined toward fever,
but the lack of a negative signal from mild-viral-LRI is also suggestive. If it is not
mere association, the network in figure 5.4 indicating that wheeze with airborne-atopy
does not resolve then suggests that there might be a long-term benefit from preventing
febrile-viral-LRI among atopic children.
We have found that asthma needs to be understood in terms of its individual en-
dotypes which may be analytically determined via the exclusivity index (equation 3.5),
and that one of the best predictors of asthma, (log of) house-dust-mite IgE in the second
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year-of-life [19], is exclusive to a particular endotype which is predictable from non-ARI
NP microbiome samples from the first seven weeks-of-life. Other associations from ARI
microbiome samples lay between various wheeze-related outcomes and certain genera.
These were detected by dual qq-plots but were not useful for prediction. In the case of
Staphylococcus the association was argued to be indicative only.
We also found that the derived variable atopy-number, the number of allergens to
which an individual was atopic, was a strong and exclusive predictor from the first two
years-of-life of fifth-year aeroatopic-wheeze. Interestingly, counting the total number of
atopic triggers was more effective than just counting the airborne ones.
We have also shown that Gaussian prior-based models like ARTIVA can be extended
for use with non-continuous data. Our augmented model then found that the occurence
of (viral -) LRI s in early childhood and especially in the first year-of-life, was led to by
airborne-atopy and wheeze instead of leading to them. Indeed, the effect was sufficiently
pronounced to lower (viral -) URI by a corresponding amount. The conclusion is not so
strong from the second year-of-life for the reasons discussed above, and the edges from
febrile-viral-LRI might be due to a merely indicative relationship. Non-aeroatopic-
wheeze was of no detectable relevance to wheeze or asthma.
Appendix A
Multiple predictors and overfitting
A.1 Multiple predictors and overfitting
Overfitting is an ubiquitous factor limiting machine learning performance. It is charac-
terised by the counter-intuitive phenomenon of a classifier’s performance degrading in
response to the inclusion of additional predictors, and caused by the machine learning
algorithm learning the training set to such excessive accuracy that it starts to fit the
noise in the signal. An alternative characterization is that testing on the training set
gives a better result than testing on an independent testing set, which is the reason such
classifiers are typically tested using cross-validation or bootstrap methods. Overfitting is
also a disincentive to add nonlinearity or additional features to a model without specific
motivation.
To study overfitting we generated multiple simulated predictors. Each simulated
predictor was generated by two Gaussian distributions, corresponding to each of the
classes, positive and negative, of the binary classification. Each of these class-dependent
distributions had its own mean and variance, where the means would normally differ
between the two classes.
When more than one simulated predictor was to be considered at once their class-
dependent distributions were generated with pre-determined correlations (0.5 unless
stated otherwise) with the corresponding distributions of the first simulated predictor.
We could, in principle, have specified all correlations among all predictors but saw little
benefit for the extra effort it would cost the user to specify the correlation matrix. We
found that just specifying a correlation with the first predictor was sufficient to explore
the effects of correlation. We constructed the required correlation matrices with R’s
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gen_corr( ) function.
Our simulations, illustrated in figure A.1 illustrate the effects of overfitting on both
logistic regression and naïve Bayes classifiers. As expected, logistic regression perfor-
mance decayed to that of random guessing with large numbers of predictors, while
naïve Bayes suffered some degradation but retained asymptotic predictive power (see
subfigures A.1a, A.1b). This is consistent with naïve Bayes being theoretically immune
to overfitting [180], subject to the quality of its implementation [113, 115, 116], while
there is no corresponding theorem for logistic regression. Neither classifier demonstrated
any degradation in performance due to over-fitting when the simulated predictors were
generated with no correlations among them, as shown in figure A.1c.
Figure A.2 demonstrates that naïve Bayes outperformed logistic regression for mul-
tiple CAS predictors. While naïve Bayes performance plateaued to a weighted mean
of individual AUCs, that of logistic regression decayed to .50 with increasing numbers
of predictors. (We chose the variables with the most Gaussian distributions, as mea-
sured by the Shapiro-Wilks test, and added them to the classifier in both ascending
and descending order. We attribute the relative performance between ascending and
descending Shapiro-Wilks index to the distributions of the best predictors.) While
prudence should always be shown when considering different data sets, the highly het-
erogeneous nature of the included predictors gives some confidence that this generic
result should be widely applicable.
A.2 Combining predictors of different quality
We then studied the effect of combining predictors of different quality. We controlled
this quality by adjusting the difference between the means of the class-dependent dis-
tributions, and also by adjusting their standard deviations. A greater difference in their
means unsurprisingly gave a higher AUC while larger standard deviations led to a lower
one.
The top two graphs in figure A.3 show the AUCs found by both logistic regression
and naïve Bayes for ensembles of two and three simulated predictors. In the top-left
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(a) Overfitting in the presence of corre-
lations was more detrimental to logistic
regression than to naïve Bayes: The cor-
relation between the class-dependent distribu-
tions of the first simulated predictor and the
corresponding distributions of the later predic-
tors was 0.5.















(b) Stronger correlations among multi-
ple predictors were detrimental to both
classifiers: The correlation between the class-
dependent distributions of the first simulated
predictor and the corresponding distributions of
the later predictors was 0.9.















(c) Overfitting did not affect simple clas-
sification in the absence of correlations:
These simulated predictors were uncorrelated.
Figure A.1: Overfitting as demonstrated by simulated predictors: All simulated
predictors had a difference in mean of one and a variance of one for both class-dependent
distributions. The plotted points are spaced at intervals of 50, with additional plots for
two, five and ten predictors.
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Figure A.2: Classifier performances with increasing numbers of CAS predic-
tors: The included predictors are those with one of the top 200 Shapiro-WilksW scores.
The four lines indicate the AUC as a function of the number of predictors. Logistic re-
gression and naïve Bayes classifier performances are plotted for each of increasing and
decreasing AUC. The logistic regression classifier has its peak performance at about
20-25 predictors and declines from then onwards with perhaps one hiatus, while the
naïve Bayes-curves decline only marginally after reaching their peaks.
graph the third predictor had a lower AUC than the first two, effected by giving the
class-dependent distributions of the third predictor a standard deviation which was
double that of the first two. The logistic regression classifier performs better with the
introduction of the weaker predictor while the naïve Bayes classifier is weakened. In
the top-right graph the first predictor is the weak one, while the other two are stronger
(standard deviations 2, 1, 1, respectively). Logistic regression performs better with
the unmatched pair, but they both improve by the same amount when another strong
predictor is added.
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This general pattern is repeated by the bottom two figures, with logistic regression
and naïve Bayes again performing equally well with a pair of equally good predictors in
the left-hand graph in which both had a relatively low AUC, while logistic regression
and naïve Bayes improved and declined, respectively but both classifiers were equally
affected by the introduction of a third predictor with a higher AUC. In this case the
difference in AUC was effected by the first two predictors each having a difference of
three between the means of their class-dependent distributions, while the remaining
predictor had a difference of one, while all class-dependent distributions had a standard
deviation of three. We again found that adding an inferior predictor degraded the
predictive performance of naïve Bayes, both in comparison to having fewer predictors
and in relation to logistic regression.
It seems advisable to avoid adding poorer predictors to predictor ensembles when
using naïve Bayes classifiers, but that this is not so important for logistic regression.
However, the performance of logistic regression will degrade with large numbers of
predictors, regardless.
After completing this work we found a paper by Subramanian and Simon [162] which
also used simulations to study over-fitting. They measured the difference in accuracy
between testing on the training set and testing on an independent test set to measure
overfitting in a range of classifiers, including logistic regression. Their approach found
that more accurate predictors were less vulnerable to overfitting, and vice versa. Indeed,
overfitting was observed among null predictors (AUC = .50), and also increased with
smaller samples.
The degree of correlation and the quality of the individual predictors determined
both the asymptotic performance of naïve Bayes and the rate of decline of logistic
regression. We therefore advocate the practice [117] of choosing predictors according
to a greedy algorithm, starting with the best predictors and proceeding in decreasing
order of individual predictive power.
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(a)
standard deviations LR NB
1, 1 .769 .769
1, 1, 2 .777 .756
(b)
standard deviations LR NB
2, 1 .774 .760
2, 1, 1 .807 .791
(c)
standard deviations LR NB
3, 3 .627 .627
3, 3, 1 .773 .739
(d)
standard deviations LR NB
1, 3 .745 .726
1, 3, 3 .745 .711
Figure A.3: Comparisons of simulations with two or three simulated predic-
tors for both logistic regression and naïve Bayes: The tables give the logistic
regression (LR) and naïve Bayes (NB) AUCs for the standard deviations corresponding
to the simulated predictors. For every predictor the difference between the means of its
distributions is one. Comparing these graphs, it appears that the inclusion of a weaker
predictor adversely affects the performance of the naïve Bayes classifier more than the
logistic regression classifier.
Appendix B
Augmentation of integer data for Gaus-
sian priors
The augmentation of Albert and Chibb [9] replaces every discrete dependent variable
Yi with a continuous variable Zi, where the subscript i indicates the sample (partici-
pant). The value of Zi is randomly generated from a truncated Gaussian distribution at
every iteration of the Gaussian prior algorithm, with the boundaries of the truncation
depending on the value of Yi.
The simplest application is when the Yi are binary. There is a single cutoff, y0 say,
to mark the difference between the two available values (0 and 1 in our work). The
value of y0 can be set arbitrarily, and remains constant throughout. It is common to
set y0 ≡ 0 but since we also deal with count data we found it more convenient to take
y0 ≡ 12 .
For a system of linear equations
A ~X + ~B = ~Y , (B.1)
we make the replacement












,∞) when Yi = 1 (B.3)
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Figure B.1: The peak of the Gaussian in the left-hand figure is in the positive range. If
the corresponding Yi = 1 then the selected Zi will be typically chosen around the peak
of the distribution, or up against the left-hand-side of the cutoff otherwise. Similarly
in the right-hand figure, the peak of the Gaussian is between one and two, with the Zi
distributed around this peak if the corresponding Yi = 2, or up against the adjacent
cutoffs, otherwise. This method allows the MCMC to also sample Z distributions.
This is illustrated in figure B.1.
When Yi can be one of a larger set of discrete values it is necessary to have more than
one cutoff. The exposition given in [9] treats the general case of Yi corresponding to
categories, and includes a step adjusting the cutoffs at each iteration. Since our discrete
data are actually count data, where the unit interval is mathematically meaningful, we














This is illustrated in figure B.1
Appendix C
Numbers of cases and controls for
important conditions
Several of our analyses involve specification of precise conditions, so the numbers of
cases and controls are provided here for the reader’s reference.
condition case/control/NA year 1 year 2 year 3 year 4 year 5
cases 68 84 83 80 89
atopy (ae) controls 136 118 117 106 80
NAs 2 4 6 20 37
cases 16 54 56 68 78
airborne-atopy controls 188 148 144 114 91
NAs 2 4 6 20 37
cases 67 63 59 54 56
wheeze controls 139 143 147 145 141
NAs 0 0 0 7 9
Table C.1: Numbers of cases and controls for binary variables included in
CAS and included in analyses
condition case/control/NA year 1 year 2 year 3 year 4 year 5
cases 8 22 22 27 30
airborne-atopy with wheeze controls 196 180 178 159 139
NAs 2 4 6 20 37
cases 8 32 34 41 48
airborne-atopy without wheeze controls 196 170 166 145 121
NAs 2 4 6 20 37
cases 57 40 37 25 20
wheeze without airborne-atopy controls 147 162 163 161 149
NAs 2 4 6 20 37
Table C.2: Numbers of cases and controls for compound binary variables




Some of the networks in chapter 5 are based on the numbers of varioius kind of infection.
We have covered only the most important infections as a compromise to brevity.






























































Figure D.1: The number of important types of infection during the first year-
of-life. Infection numbers not shown can be inferred
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Figure D.2: The number of important types of infection during the second
year-of-life.
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Figure D.3: The number of important types of infection during the third
year-of-life.
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Figure D.4: The number of important types of infection during the fourth
year-of-life.
127


















































Figure D.5: The number of important types of infection during the fifth year-
of-life.
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Figure D.6: The number of important types of viral infection during the first
year-of-life.
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Figure D.7: The number of important types of viral infection during the
second year-of-life.
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Figure D.8: The number of important types of viral infection during the third
year-of-life.
Appendix E
QQ-plots to supplement discussion in
section 4.2
E.1 QQ-plots illustrating the relationship between Haemophilus and
fifth-year atopic-wheeze

























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze




























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze
Figure E.1: Remaining qq-plots demonstrating a link between an elevated
relative abundance of Haemophilus in biomes from samples taken when the
participant was suffering a respiratory infection, and atopic-wheeze in the
fifth year-of-life:
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+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze



























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze



























+ve fifth-year atopic wheeze
-ve fifth-year atopic wheeze
QQ-plots demonstrating a link between an elevated relative abundance of
Haemophilus in biomes from samples taken when the participant was suf-
fering a respiratory infection, and atopic-wheeze in the fifth year-of-life:
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E.2 QQ-plots illustrating the relationship between Moraxella and
fifth-year wheeze

























































Figure E.2: Remaining qq-plots demonstrating a link between an elevated
relative abundance of Moraxella in biomes from samples taken when the
participant was suffering a respiratory infection, and lack of wheeze in the
fifth year-of-life:
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QQ-plots demonstrating a link between an elevated relative abundance of
Moraxella in biomes from samples taken when the participant was suffering
a respiratory infection, and lack of wheeze in the fifth year-of-life: The effect
is less pronounced than for atopic-wheeze specifically, indicating that this effect is atopy
related.
Appendix F
Method for acquiring genera abun-
dances from the NP microbiome
The following is extracted with minimal modification from supplementary S1 of Teo et
al. [7], which includes further details less relevant to this thesis.
F.1 Aspirate sample taking
Healthy NP Aspirates (NPAs) were collected from participants by study clinicians dur-
ing planned visits at approximately 2 months, 6 months and 12 months of age, after
the child had been free from any symptoms of respiratory illness for a period of at least
4 weeks. Parents were also asked to report to the study clinicians whenever the child
showed symptoms of an Acute Respiratory Illness (ARI ), at which point the family was
visited within 48 hours by a study nurse who recorded clinical details of the infection
and collected an NPA from the child. Clinical data recorded included the presence of
fever, wheeze or rattly chest and any medications taken (including antibiotics). Each
ARI was classified as either an LRI or a URI. The material in each NPA was divided
into four aliquots and stored at −80◦C.
F.2 DNA extraction and bacterial 16S rRNA amplicon sequencing
One aliquot each of 1,021 NPAs was used for 16S rRNA microbiome profiling. These
include 487 out of 561 healthy NPAs collected from visits at 2 months, 6 months and
12 months of age; 380 out of 381 LRI s reported during the same period; and 154 out of
782 URI s (random selection of 0-2 URI s per infant). Overall, 397 healthy NPAs, 326
LRI s and 101 URI s were profiled for both virus and bacteria.
Total DNA was extracted and sequenced by MiSeq sequencing, where the ampli-
cons were prepared using primers spanning the V4 region of the 16S rRNA gene and
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containing barcoded reverse primers as published by Caporaso et al. [181].
Amplification of each sample was performed in quadruplicate to obtain enough am-
plicon for sequencing. Each plate also included a positive control (gDNA from S. en-
terica strain LT2, a bacterium not normally associated with the respiratory system
(ATCC#700720D-5, USA)), and water as a negative control.
Due to the high throughput nature of this study, the sample DNA that was added
into each PCR reaction was not quantified and normalized. Batch effects were instead
mitigated by using a fixed volume (4 µL) of DNA template per well.
F.3 Quality control and taxonomic assignment
Quadruplicate sample amplicons were combined into a single well on a polymerase
chain reaction (PCR) plate, then transferred to a fresh round-bottom polystyrene plate
where they were purified. Amplicon quantitation was performed using the Quant-iT
PicoGreen dsDNA quantitation kit (Life Technologies, Victoria, Australia) and fluores-
cence was determined on a Wallac Victor3 Multilabel counter (Perkin Elmer). PCR
samples were equalized to 2nM concentration (a neat aliquot was used where a sample
fell below this concentration) and pools of 48, 60 or 96 barcoded samples were generated
and sent for sequencing.
Paired end reads were merged and then quality filtered. A total of 33 million se-
quences were filtered out (13%), leaving 219 million for analysis. Sequences of sufficient
quality were assigned to Operational Taxonomic Units (OTUs) using the closed refer-
ence method in QIIME v1.8 [182] with the Greengenes 99% OTU reference set, version
135 [](54). This reference set consists of more than 200,000 representative sequences
obtained from clustering all sequences from the Greengenes reference database at 99%
sequence similarity. Briefly, the closed reference OTU picking uses UCLUST [183] to
search each sequence against the reference set, and assigns the sequence to an OTU
based on the best hit at ≥ 99% sequence identity. Sequences that did not match the
reference database (3%) were excluded from the analysis. This left an average of more
than 200,000 (interquartile range: 108,000 - 255,000; 8 samples with less than 1000
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reads) taxonomy-assigned sequences for each NPA.
The relative abundance of each OTU was calculated for each NPA (i.e. reads match-
ing the OTU, divided by total taxonomy-assigned reads for that sample). Most analyses
were summarised at genus level, whereby all OTUs assigned to the same genus were




Legend showing correspondence between the shade with which an edge is rendered
and its posterior probability in the given DBN. Black edges have near-unit probability,




Mean-imputed DBNs with infection
Most of our DBNs were inferred after removing records with missing data in any of
the variables. While this generally worked well, it was problematic for data in which
some years-of-life had a lot more missing data than the other years-of-life. The most
important example was infection data, for which the fourth and fifth years-of-life had a
lot more missing data than the first three. Over the next few pages we present alterna-
tive DBNs for which missing data was mean-imputed instead of discarding incomplete
records.
Figure H.1: Airborne-atopy and wheeze each led to severe-LRI but not to
URI or other LRI. Neither URI nor LRI led to airborne-atopy nor wheeze:
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Figure H.2: Wheeze and airborne-atopy led to wheezy-LRI. There was no
negative link to URI :
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Figure H.3: All atopy and wheeze led to severe-LRI, aeroatopic-wheeze most
strongly. Aeroatopic-wheeze also led against URI , but with a lower posterior
than in figure 5.9:
144 Appendix H: Mean-imputed DBNs with infection
Figure H.4: Airborne-atopy and wheeze lead to wheezy-LRI. The two together
have the strongest effect, and also lead away from URI, indicating that they
assist infectious agents in penetrating the lungs:
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Figure H.5: Airborne-atopy with wheeze, and to a lesser extent without




I.1 Mild-viral-LRI and the number of airborne atopic allergens
Figure 5.24 indicates a negative link from mild-viral-LRI in the first year-of-life to
aeroatopy-number, but only when the mild-viral-LRI are accompanied by airborne-
atopy, and this was supported by the χ-squared test, as shown in table 5.7. We also
confirmed the lack of a link in the absence of airborne-atopy with the χ-squared test and
the results are shown here in table I.1.
mild-viral-LRI
aeroatopy-number previous year same year following year
First year-of-life NA .1117 .2429
Second year-of-life .1773 .01672 .8141
Third year-of-life .862 .652 NA
Table I.1: χ-squared test p-values of the interaction between aeroatopy-
number and the number of mild-viral-LRI in the previous, same and follow-
ing year, where the mild-viral-LRI are not accompanied by airborne-atopy :
With the exception of the second year-of-life, there is no evidence of a relationship be-
tween these variables, and even that second-year p-value is large compared to those in
other tables. This finding is consistent with the network in figure 5.24
148 Appendix I: Other supplementary material
I.2 Separating severe-viral-LRI into wheezy- and febrile- viral-LRI
In figures 5.7 and 5.8 we observed that splitting severe-LRI into it febrile- and wheezy-
LRI, gave an improved DBN clearly signalling the importance of wheezy-LRI. The DBNs
for severe-viral-LRI did not follow the same progression, probably due to viral data
being limited to the first three years-of-life.
Figure I.1: Airborne-atopy lead against viral-URI, with intermediate poste-
rior: Splitting severe-viral-LRI into its febrile and wheezy categories did not improve
the network in the same way that splitting severe-LRI did (see figure 5.8).
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I.3 Aeroatopy-number and IgE dynamics
Subsection 5.7.1 discussed interactions between atopy-number and (log of) IgE titres,
based on the network in figure 5.29. The corresponding network (figure I.2), is very
similar but of poorer quality.
Figure I.2: Interaction of aeroatopy-number (log of) IgEs: Very similar to figure




We present here some lists of the terms used commonly throughout this thesis.
J.1 Respiratory tract infections
Basic infections:
There is frequent reference to respiratory tract infections, which are variants on these
two:
LRI lower respiratory tract infections, or the number thereof, during a given year-of-
life.
URI upper respiratory tract infections, or the number thereof, during a given year-of-
life. To be clear, this refers to repiratory tract infections which do not reach the
lower respiratory tract.
Whether we are referring to the infections or to the number of them is clear from context.
Types of infection:
The LRI s, have many subtypes, described here:
febrile- the infections were accompanied by fever. CAS also applies this to URI, but
we have not used febrile-URI in this thesis.
mild- the infections were accompanied by neither fever nor wheeze,
purely-febrile- the infections were accompanied by fever but not by wheeze,
purely-wheezy- the infections were accompanied by wheeze but not by fever,
severe- the infections were accompanied by fever, wheeze, or both,
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wheezy- the infections were accompanied by wheeze.
Viral-status:
Swabs of the NP were taken during respiratory infections and tested for, among other
things, the presence of virii . Which specific virii were present was determined by PCR
analysis, but our work is only concerned with whether any virus was present. Both
URI s and LRI s were sometimes accompanied by virii , denoted by:
viral- at least one virus was detected during the infections,
non-viral- no virus was detected during the infections.




airborne-atopy atopy to any airborne allergen. The airborne allergens are cat, mould,
couch, rye and house-dust-mite (binary), while phadiatop is a mixture of airborne
allergens. The individual is then said to be aeroatopic to that aeroallergen (bi-
nary),
atopy having a blood concentration ≥ .35kU/L for any allergen-specific antibody. The
individual is then said to be atopic to that allergen (binary),
nonairborne-atopy atopy where none of the allergens to which the individual is atopic
are airborne (binary),
aeroatopy-number the number of airborne allergens to which the individual is atopic.
This was not one of the CAS variables but derived from the various aeroallergen
IgE s.
atopy-number the number of allergens to which the individual is atopic. This was
not one of the CAS variables but derived from the various allergen IgE s.
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ARI samples Samples of the NP microbiome taken during the course of a respiratory
infection,
non-ARI samples Samples of the NP microbiome taken in the absence of a respira-
tory infection,
AUC Area Under the Curve, description in subsection 2.3.6,
BN Bayesian Network, described in subsection 2.2.1,
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DBN Dynamic Bayesian Network, described in subsection 2.2.4,
wheeze whether a child had wheezed during a given year-of-life, as diagnosed by a
doctor (binary),
transient wheeze whether wheeze was present during any of the first three years-of-
life and absent in the fifth (binary),
year-of-life time periods were indicated according to the age of the individual and
not from any given date. Similarly, first-year, second-year etc. are referring to
the age of the individual and not to the age of the study. The corresponding
understanding holds for month-of-life and days-of-life.
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